Foam-based interfacing structure

Information

  • Patent Grant
  • 12070552
  • Patent Number
    12,070,552
  • Date Filed
    Thursday, February 28, 2019
    5 years ago
  • Date Issued
    Tuesday, August 27, 2024
    3 months ago
Abstract
An interfacing structure is arranged to cooperate with a frame to contact with the skin of a patient. The interfacing structure includes a clip portion joined to a cushioning component. The frame is more rigid than the clip portion and the clip portion is more rigid than the cushioning component.
Description
FIELD OF THE INVENTION

The present invention relates to an interface between a human and a piece of equipment, for example respiratory devices that include a foam-based interfacing structure.


BACKGROUND OF THE INVENTION

In a number of fields, such as respiratory therapy, apparatus for delivery of therapy includes a rigid component and a soft, cushioning component positioned between a patient and the rigid component.


In the case of a respiratory device, the rigid component may be a mask frame defining a nose and/or mouth-receiving chamber. The mask frame may include a flange around its periphery or other connecting means. The cushioning component may be glued or otherwise coupled to the flange or connecting means.


The cushioning component may form a seal with the skin of the patient in some forms of respiratory therapy. In other devices, for example headphones, it may not be necessary for a seal to be formed.


SUMMARY OF THE INVENTION

A first aspect of the invention is to provide a mask assembly with a foam interfacing structure.


Another aspect of the invention is to provide a mask assembly with a foam interfacing structure where at least a part of the foam (e.g., an unskinned part of the foam) is in direct contact with the skin of the mask user.


Another aspect of the invention is to provide a mask assembly with a foam interfacing structure where the foam is unskinned and has a cellular structure of the foam in direct contact with the skin of the mask user.


Another aspect of the invention is to provide a mask assembly with a removable foam interfacing structure.


Another aspect of the invention is to provide a mask assembly with at least two different types of removably replaceable interfacing structures.


Another aspect of the invention is to include a softer interfacing structure having portion adapted for engagement with a more rigid component.


Another aspect of the invention is to provide a respiratory mask assembly including a frame and an interfacing structure wherein the interfacing structure includes a foam-based cushion component and a clip portion adapted for removable engagement with the frame portion.


Another aspect of the invention is to provide a support structure for a cushioning component wherein the support structure supports the cushioning element on one side and allows movement on another side.


Another aspect of the invention relates to a cushion for a respiratory mask including a clip portion and a cushioning component wherein the cushioning component is constructed from a foam material and the clip portion is narrower than the cushioning component.


Another aspect of the invention relates to a respiratory mask assembly including a frame having a channel and an interfacing structure including a clip portion adapted for interference seal and retention in the channel. The interfacing structure includes a cushion component constructed from foam and having a wider width than the clip portion.


Another aspect is a foam-based cushioning component preferably having a first cross-section in a nasal bridge region, a second cross-section in a lip region and a third cross-section in the cheek region.


Another aspect is a method of manufacturing a cushioning component, e.g., die cutting and/or machining, etc.


Another aspect is a method of insert molding a clip component to a cushioning component to form an interfacing structure.


Another aspect is a cushioning component for use with a mask, wherein the cushioning component is constructed of foam material. A patient contacting surface, that is adapted to contact a patient, in use, may have a rounded cross sectional profile and a base surface opposed to the patient contacting surface.


Another aspect is a removable interfacing structure for use with a mask including a cushioning component constructed of foam material wherein a patient contacting surface that is adapted to contact a patient, in use, has a rounded cross sectional profile and a base surface opposed to the patient contacting surface is joined to a clip portion, and wherein the clip portion is adapted to be removably joined to a frame of the mask.


Another aspect is a mask including a removable interfacing structure and a frame, wherein the interfacing structure includes a clip portion and a cushioning component constructed of foam material having a patient contacting surface that is adapted to contact a patient, in use, has a rounded cross sectional profile and a base surface opposed to the patient contacting surface is joined to the clip portion, and wherein the clip portion is adapted to be removably joined to a frame of the mask.


Another aspect is a mask including a frame and an interfacing structure, wherein the interfacing structure includes a clip portion joined to cushioning component, and wherein the frame is more rigid than the clip portion and the clip portion is more rigid than the cushioning portion.


Another aspect is a cushioning component for use with a mask, wherein at least a portion of the cross section of the cushioning component includes an inner side defined by the side facing the centre of the mask, an outer side defined by a side facing away from the centre of the mask and a base side facing the frame or clip portion, wherein the length of outer side is greater than the inner side.


Another aspect is an interfacing structure for a mask including a clip portion joined to a cushioning component, wherein an upper surface of the clip portion is joined to a base surface of the cushioning component and wherein at least a portion of the upper surface is angled to provide a moment force on cushioning component, when force is applied into the cushioning component.


Another aspect is an interfacing structure for a mask including a clip portion joined to a cushioning component, wherein an upper surface of the clip portion is joined to a base surface of the cushioning component and wherein the cross sectional width of the clip portion is less than the cross sectional width of the cushioning component.


Another aspect is a cushioning component for use with a mask, wherein at least a portion of the cross section of the cushioning component includes an inner side defined by the side facing the centre of the mask, an outer side defined by a side facing away from the centre of the mask and a base side facing the frame or clip portion, wherein the outer side further includes at least an upper and a lower portion, wherein the upper portion is positioned at a reduced angle in comparison to the lower portion.


Another aspect is a nasal mask including a frame removably connected to an interfacing structure, wherein the interfacing structure includes a cushioning component constructed of foam material, and wherein the height of the interfacing structure is reduced in relation to region that is adapted to contact the upper lip region of a patient's face.


One aspect of the present technology relates to a respiratory mask including a frame, a foam cushion and a substructure. The mask includes a nose receiving cavity. The cushion includes at least two sides: an inner side wall, which may be a wall at least partially facing the cavity; and an outer side wall. The foam cushion is soft and conforming. The substructure is constructed from a more rigid material. The foam cushion is adapted to form a seal with at least one region of a face of a patient. In use the foam cushion is supported by the substructure. A connecting surface of the substructure is defined. A patient side of the foam cushion is defined. A non-patient side of the cushion is defined. In use the non-patient side of the cushion is arranged adjacent the connecting surface of the substructure. In one form the foam cushion is glued to the substructure. In another form the foam cushion is insert moulded with the substructure. A first region of the face is defined as a corner of the mouth of the patient. A second region of the face is defined as a chin region, or alternatively a lip region of the face of the patient. An interior region of the cushion is defined as the region or cavity into which a nose of a patient is inserted in use.


In one form, a part of the connecting surface in use adjacent the first region is structured in to direct a corresponding portion of the foam cushion in an inward direction towards the interior region of the cushion in the first region in use. The cross-section of the cushion defines a radial axis and a longitudinal axis is normal to said radial axis. Preferably, at least a portion of the foam cushion is adapted to rotate towards the centre of the mask about said longitudinal axis when pressure is applied into the cushion by the patient's face and wherein at least a portion of the outer side wall of said cushion is adapted to form a seal against the face of a patient.


Wherein portions of the cushion rotate or roll inwards towards the centre of the mask. The feature of rolling or rotating inwards may prevent or limits the possibility of the seal “blowing out” when air pressure is applied to the mask cavity. “Blowing out” is defined by the seal between the cushion and the patient's face breaking due to pressure exerted by air pressure lifting the cushion from a sealing relationship with the face.


In one form, a part of the connecting surface in use adjacent the second region is structured to direct the foam in an outward direction away from the interior region of the cushion in the second region in use. The cross-section of the cushion defines a radial axis and a longitudinal axis is normal to said radial axis. Preferably, at least a portion of the foam cushion is adapted to rotate away from the centre of the mask about said longitudinal axis when pressure is applied into the cushion by the patient's face and wherein at least a portion of the outer side wall of said cushion is adapted to form a seal against the face of a patient.


Preferably, further portions of the cushion may rotate inwards or outwards relative to the centre of the mask in positions defined as being proximal to the patient's chin. In regions or portions of the cushion that can rotate or roll inwards and outwards, this rotation may allow for seal to accommodate different sizes of chin and/or accommodate moderate amounts of mouth or jaw movement that may otherwise destruct the seal formed between the mask and the patient's face.


Another aspect of the present technology is a foam cushion for a respiratory mask wherein the cushion includes a face-contacting portion arranged in use to be adjacent the face of the patient.


Preferably in at least some regions of the face contacting portion, a cross section of the cushion tapers from a wider cross-section to a narrower cross-section closer to the face. The tapered portion defines an inside surface adjacent an interior of the cushion and an outside surface. The inside surface and the outside surface may be adjacent, in another form they may be non-adjacent. The inside and outside surfaces may be arranged at an acute angle with respect to one another. In one form in cross-section the outside surface is longer than the inside surface in certain regions of the cushion, preferably in the nasal bridge region, or in the cheek region, or more preferably in both. In one form the inside and outside surfaces have the same length in a chin region. In one form in a lip region the inside surface is longer than the outside surface in cross-section.


In one form, the cushion is structured to at least partially form a seal on an outside surface of a face in a chin region of the cushion. We have found that a tapered sealing portion may improve the seal.


Other aspects are directed to methods for manufacturing the foam cushioning elements described above.


Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:



FIG. 1 shows a side view of a mask assembly including a foam interfacing structure according to an embodiment of the invention;



FIG. 2 shows a schematic diagram of a channel of a portion of a mask frame and a clip portion of an interfacing structure retained by an interference fit according to an embodiment of the invention;



FIGS. 3a, 3b, and 3c show a range of rib engagement fitting arrangements between a mask frame and a clip portion of an interfacing structure according to embodiments of the invention;



FIG. 4a shows a patient contacting side of an interfacing structure according to an embodiment of the invention;



FIG. 4b shows a bottom view of the interfacing structure of FIG. 4a;



FIG. 4c shows a top view of the interfacing structure of FIG. 4a;



FIG. 4d shows a side view of the interfacing structure of FIG. 4a;



FIG. 4e shows a frame contacting side of the interfacing structure of FIG. 4a;



FIG. 4f shows a patient contacting side isometric view of the interfacing structure of FIG. 4a;



FIG. 4g shows a frame contacting side isometric view of the interfacing structure of FIG. 4a;



FIG. 5a is a plan view showing a die cut interfacing structure wherein the clip portion includes a slot for engagement with the frame according to an embodiment of the invention;



FIG. 5b is an isometric view of the interfacing structure shown in FIG. 5a;



FIG. 5c is an assembly view of the interfacing structure shown in FIG. 5a with a mask frame;



FIG. 6a shows a cross-section from a prior art nasal mask with foam cushion;



FIG. 6b shows a detail in the nasal bridge region of the mask of FIG. 6a;



FIG. 7a shows an elevation view detail from the frame side of the interfacing structure shown in FIG. 4e;



FIG. 7b is a cross-section along line 7b-7b of FIG. 7a;



FIG. 7c is a cross-sectional view showing the interfacing structure of FIGS. 7a and 7b in use;



FIG. 8 is a cross-sectional view showing the assembly of the interfacing structure of FIGS. 7a and 7b and a frame according to an embodiment of the invention;



FIGS. 9a to 9d show various views of a foam-based interfacing structure according to an embodiment of the present invention;



FIGS. 10a to 10c show various views of a foam-based interfacing structure according to another embodiment of the present invention;



FIGS. 11a to 11c show various views of a foam-based interfacing structure according to another embodiment of the present invention;



FIGS. 12a to 12f show various views of a foam-based interfacing structure according to another embodiment of the present invention;



FIG. 13 is a perspective view of a clip portion according to an embodiment of the present invention;



FIGS. 14a to 14f show various views of a foam-based interfacing structure according to an embodiment of the present invention;



FIGS. 15a to 15e show various views of a cushion-to-frame component of the interfacing structure shown in FIGS. 14a to 14f;



FIGS. 16a to 16i show various views of the cushioning component of the interfacing structure shown in FIGS. 14a to 14f;



FIGS. 17a to 17h illustrate a tool and manufacturing process for manufacturing an interfacing structure according to an embodiment of the present invention;



FIGS. 18a to 18c show various views of a tool for molding a clip portion according to an embodiment of the present invention;



FIG. 19 is a front view of a further embodiment of a full face cushioning component;



FIGS. 20-25 depict various cross-sectional views of the embodiment shown in FIG. 19;



FIG. 26 is a front view of a further embodiment showing an interfacing structure for use with a full face mask including a cushioning component and clip portion;



FIGS. 27-32 depict various cross-sectional views of the embodiment shown in FIG. 26. FIG. 29 defines a horizontal plane of connection between the cushion and the clip portion. In FIGS. 30 to 32, the plane of connection is at an angle with respect to the horizontal. In FIG. 30, the plane of connection is at a downward angle when moving from the outside to the inside of the interfacing portion. In FIG. 32, the plane of connection is at an upward angle when moving from the outside to the inside of the interfacing portion.



FIG. 33 is a perspective view of full face interfacing structure including a cushioning component and clip portion;



FIG. 34 is a side view of the embodiment shown in FIG. 33;



FIG. 35 is a top view of the embodiment shown in FIG. 33;



FIG. 36 is a bottom view of the embodiment shown in FIG. 33;



FIG. 37 is a back view of the embodiment shown in FIG. 33;



FIG. 38 is a front view of the embodiment shown in FIG. 33;



FIG. 39 is a front view of a further embodiment of a interfacing structure for use with a nasal mask;



FIG. 40 is a top view of the embodiment shown in FIG. 39;



FIG. 41 is a bottom view of the embodiment shown in FIG. 39;



FIG. 42 is a side view of the embodiment shown in FIG. 39;



FIG. 43 is a back view of the embodiment shown in FIG. 39;



FIG. 44 is a front view of a further embodiment of an interfacing structure for use with a nasal mask;



FIGS. 45-47 depict various cross-sectional views of the embodiment shown in FIG. 44;



FIG. 48 is a chart showing exemplary material properties for a cushion component according to an embodiment of the invention;



FIG. 49 is a chart showing exemplary material properties for a clip portion according to an embodiment of the invention;



FIGS. 50-1, 50-2, 51-1, 51-2, 52-1, 52-2, 53-1, 53-2, 54-1, 54-2, 55-1, 55-2, 56-1, 56-2, 57-1, and 57-2 illustrate alternative mechanisms for attaching a clip portion



FIGS. 58 and 59 illustrate the rolling effect of a cushioning component according to an embodiment of the invention;



FIGS. 60-1 to 60-8 illustrate different parameters and apparatus for testing air permeability according to an embodiment of the invention;



FIG. 61 illustrates apparatus for testing hardness according to an embodiment of the invention;



FIGS. 62-1 to 62-2 illustrate different parameters and apparatus for testing tensile strength according to an embodiment of the invention;



FIGS. 63-1 to 63-4 illustrate different parameters and apparatus for testing tear resistance according to an embodiment of the invention; and



FIG. 64 illustrates apparatus for testing total mask flow according to an embodiment of the invention.





DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS

The following description is provided in relation to several embodiments which may share common characteristics and features. It is to be understood that one or more features of any one embodiment may be combinable with one or more features of the other embodiments. In addition, any single feature or combination of features in any of the embodiments may constitute additional embodiments.


In this specification, the word “comprising” is to be understood in its “open” sense, that is, in the sense of “including”, and thus not limited to its “closed” sense, that is the sense of “consisting only of”. A corresponding meaning is to be attributed to the corresponding words “comprise”, “comprised” and “comprises” where they appear.


The term “air” will be taken to include breathable gases, for example air with supplemental oxygen.


The term “seal” will be taken to mean to reduce the flow of air between the pressurized interior of the mask and the ambient conditions to a level sufficient to maintain a therapeutic pressure in the airways to effect treatment. Hence in some cases, there may be an air tight seal, in other cases there may be a small leak.


1. Introduction

A mask assembly used to facilitate the delivery of a supply of air or breathable gas to the entrance of the airways of a patient typically includes a generally soft, conforming interfacing structure, at least a portion of which is in contact with the patient's face and a stabilizing structure that positions and retains the interfacing structure in a suitable position with respect to the patient. The mask assembly typically includes some form of anchor point to which various components may be connected, or about which they may be arranged. In this specification, this anchor point will be referred to as the frame.


By way of example, the stabilizing structure of the mask assembly may be called “headgear” and both the headgear and interfacing structure may be connected to a frame. In some forms of mask, the boundary lines between the different components may be blurred. For example, aspects of frame and headgear may be combined.


The interfacing structure may perform two or more functions: (i) a cushioning function, performed by a cushioning component, and (ii) an interconnection function, performed by a cushion-to-frame component or clip portion. Generally, in this specification the term “clip” or “clip portion” may describe the aforementioned clip portion or a cushion to frame component for securing the cushioning component to a frame of a mask.


Forming the interfacing structure from two separate elements enables each to have different properties, such as different densities or air permeabilities as suits their different roles, as will be described in more detail in the following sections. Furthermore, the different properties of different materials can act to influence the other component. For example, a more rigid clip or cushion-to-frame portion can act as a support structure for a softer cushioning component.


However, in another embodiment, the interfacing structure may be constructed from a single component with different properties in different regions of the interfacing structure. Furthermore, the interfacing structure may be formed from more than two components.


The interfacing structure may be constructed and arranged to apply air or breathable gas to both the nose and mouth (a “nose & mouth” or “full-face” mask), or to the just the nose (a “nose” or “nasal” mask), or just the mouth (a “mouth” mask).


The statement “more rigid” may be understood to mean less flexible and/or stiffer.


2. Cushion Component

2.1 Material


In one form, the cushioning component may be made from an unskinned, low density, permeable foam. In a preferred embodiment, the cushion component is constructed from a low resilience viscoelastic polyurethane foam. The cushioning component material may be manufactured from a free rising slabstock foam process. In other embodiments the material may be manufactured by other processes such as molding or other known processes used to produce soft and cellular materials. One or more fabrication steps (known as conversion techniques) may then be applied to the material to partially or completely form the geometry of the cushion component. These conversion techniques are described herein and in other related specifications referenced herein. Such a foam material and conversion techniques are disclosed in PCT Publication Nos. WO 2008/011682, published Jan. 31, 2008, and WO 2008/070929, published Jun. 19, 2008, each of which is incorporated herein by reference in its entirety. In one form, the cushioning component may be formed in whole or in part by a known method such as die cutting. Die cutting is disclosed in PCT Application PCT/AU2009/000262, filed Mar. 4, 2009. In another form the cushioning component may be formed in whole or in part by using other methods such as those disclosed in AU 2008904769 and AU 2008904778.


Most foam material production techniques produce a material that has a substantially skinned material such that the density of the material at the surface is greater than the density of the material's bulk (internal) properties. The utilization of particular manufacturing techniques, such as foam conversion processes involving cutting, may allow the production of a unskinned cushioning component such that the bulk properties of the cellular material are exposed at the surface of the cushioning component, providing a number of advantages to the design, manufacture and performance of the mask assembly.


The unskinned cushion component provides improved sealing, comfort and fit range performance, sealing properties sufficient to not require a silicone membrane, and a unskinned mask assembly that allows utilization of the bulk properties of the unskinned material, e.g., porosity for breathability, fine cell structure for a comfortable feel.


2.2 Shape


The interfacing structure is preferably constructed and arranged to have a three dimensional shape defined in part by a locus of points surrounding and complementary to the entrance to the relevant airways. Furthermore, the interfacing structure has a cross-section chosen at different points around its perimeter to provide efficacy and comfort by being suitably shaped to adapt and conform to the face of the user forming a compression-type seal. In another configuration, a flap-type seal is formed.


The shape of the interfacing structure may be adapted to allow the cushioning component to provide a better fit and seal against the face of the patient.


In an embodiment, the geometry of the cushion may be at least partly determined by the geometry of the frame to which it is to be attached. For example, the general shape of a small size cushion may be different than the general shape of a large size cushion because the small and large size frames may be different, e.g., the small may be more stout or wide while the large may be more elongated and thinner.


2.2.1 Full Face Mask



FIGS. 16g to 16i show various cross-sections through one embodiment of the cushioning component 932 (origin of cross section shown in FIG. 16f). FIG. 19 shows an alternative embodiment of the present invention with corresponding cross sections in FIGS. 20-25.



FIGS. 33-38 depict a further preferred embodiment of a interfacing structure wherein the interfacing structure includes a co-molded or otherwise attached cushioning component and a clip portion


Preferably, the full face masks depicted in this specification may have cushioning components about 105-110 mm in width (as measured from the outer most edges of the base surfaces); and a length of between 120-150 mm.


Nasal Bridge Region


As shown in FIG. 16g, the cross section at the nasal bridge region NB is generally triangular. The cross section at the nasal bridge region NB may also be another other reasonable shape, such as generally rectangular, oval, octagonal etc. In addition, it is possible for the cross section at the nasal bridge region to include a shape with generally rounded or curved corners. The cross section at the nasal bridge region may also be an irregular shape. FIG. 20 shows an alternative cross section for the nasal bridge region.


There is a radius r1 at the apex 2010 of the cross section, that may be relatively small or sharp radius at the nasal bridge region NB. For example, radius r1 may be between 1 to 4 mm. This relatively small or sharp radius at radius r1 provides the advantage that the cushioning component is kept away from the patient's eyes, especially when the cushioning component is compressed and inflated with air pressure in use. The relatively small or sharp radius at radius r1 may also enable minimal contact of the mask with the patient's skin, so as to make the mask feel more comfortable and less obtrusive.


As best shown in FIG. 20, apex 2010 of the generally triangular cross section may be skewed or offset. The apexes or the corners of the generally triangular cross sectional may be rounded to promote a better fit with the patient and/or a better seal. This offset is shown on FIG. 20, where apex 2010 and center line 2015 are spaced by distance 2020. Distance 2020 may be preferably around 1-2 mm at the position proximal to the patient's nose. The comparable offset in the cushioning component about the portion adapted to cover the bottom lip of the patient is preferably 8 mm. The comparable offset in the cushioning component about the portion adapted to cover the cheeks of the patient is preferably 1.25 mm. FIG. 20 demonstrates an offset towards the inner edge of the cushioning component. Alternatively the apex may be skewed, or over the outer edge of the cushioning component.


Additionally, the generally triangular cross section of the cushioning portion may also additionally be defined has having three sides: an inner side which faces into the centre of the mask; an outer side facing away from the centre of the mask and a base surface, which may be adapted to be joined to a clip portion, at least in part.


The outer side of surface of the cushioning portion is generally adapted to be longer than the inner surface. This may allow the cushioning component to, in effect, roll, bend or move inwards. The rolling motion leads to an extension of the sealing surface formed between the skin of the patient and the cushioning component. As the cushioning component is depressed, the contact region against the patient's skin is lengthened from the minimum contact point which is the apex to at least partially extending along the outer surface or side of the cushioning component.


For example, the apex of the triangle that contacts the user's face (FIG. 58) enables the cushion component 932 to deflect or roll such that if the apex is towards the inner part of the cushion component, the cushion component will roll inwards and over the clip portion 934 about hinge point 939. Air pressure AP from the CPAP device (FIG. 59) acts on the back of the rolled section of the cushion component 932 such that the air pressure forces the cushion component into sealing engagement on the patient's face.


The rolling effect or the turning moment force, when the mask is pressed onto the face, can be also increased or assisted the positioning or shape of the clip portion attached to the cushioning portion. Preferably, the clip portion 3234 may be joined to the base surface of the cross section of the cushioning component. More preferably, the clip is mounted proximal to the outer side of the cushioning component, and provides little or no support relative to the inner side of the cushioning component. Preferably, the clip portion may not generally support the inner side of the cushioning component.


Preferably, the clip portion includes a stepped configuration when viewed in accordance with its cross section. In FIGS. 27-32, a preferred clip portion is joined to a cushioning portion. The stepped configuration is adapted to mate with a corresponding groove, slot or recess in the frame to provide a seal. In this embodiment, the step formation is oriented towards the outer side of the cushioning component for ease of use by the patient.


Preferably, the clip portion is joined to the cushioning component by an upper side. The upper side of the clip portion may be shaped to assist with: sealing of the cushioning component; comfort; and/or the aforementioned rolling effect of the cushioning component. In FIGS. 30-31, the upper side of the clip portion has been angled towards the centre of the mask by lengthening the outer side of the clip portion relative to the shorter inner side of the clip portion. This angling of the upper surface of the clip portion is adapted to aid or assist in the rolling in effect of the cushioning component. Additionally, in the embodiments shown in FIGS. 26-32, the angled upper side of the clip portion has been included on the lower corners of the mask. For example, as shown in FIGS. 30 and 31, the upper surface of the clip portion is angled to enhance rolling and sealing in lower cheek and lip regions (e.g., a1 and a2 between about 0-20°). As shown in FIG. 32, the angle of the upper surface in the chin region (e.g., a3 between about 0-20°) is oriented opposite that in the lower cheek and lip regions (e.g., the bottom lip region) (FIGS. 30 and 31), e.g., for manufacturability.


Preferably, the upper corner which is adapted to engage the nasal bridge of the patient, the upper surface of the clip portion is flat and not angled towards to the centre of the mask. This is generally because the region around the nose doesn't require as much “roll” as the sealing area against the sides of the nose is relatively long compared the regions around or about the cheeks of the patient. This feature is demonstrated in FIGS. 27 and 28.


Preferably, the nasal bridge region also includes a modification to the base surface, wherein the base surface has been reduced or shortened to thereby reduce the volume of foam material rolled inwards at the nasal bridge.



FIG. 32 depicts the interfacing structure wherein the upper surface of the clip surface has been angled outwards relative to the centre of the mask. This reduces the effect of “roll in” in the predetermined regions including this outwardly disposed angle of the upper surface. Generally, the outwardly disposed angle of the upper surface is suitable for regions requiring reduced “roll in” such as around the bottom lip or around the upper lip (in the nasal mask configurations). Another way to regulate “roll in” is by changing the amount of overhang of the cushioning component with respect to the clip portion.


As shown in FIG. 16f, the inner apex 2050 of the cushion has the radius of curvature of between 3 to 10 mm (most preferably 3-5 mm). This is similarly shown in FIG. 19, where the inner apex 2050 of the cushion has the radius of curvature. The size of this radius may affect the durability, and more specifically the tear strength of this region.


As shown on FIGS. 16g and 20, inner edge 2090 may have an angle 2100 from the base of the cushioning component. Angle 2100 may influence the amount of the cushioning component that may contact the patient. For example, angle 2100 shown in FIG. 16f may be larger than angle 2100 shown in FIG. 20, such that more of the cushioning component in FIG. 16f may contact the patient's face than that of FIG. 20. Preferably, angle 2100 may be about 90-95 degrees. The angle of the outer side or edge meeting the base surface is preferably between 78-83. Preferably, the angle by which the outer side meets with the base surface is generally less than the angle formed between the inner side and the base surface.


The most preferred maximum width of the nose bridge region (as measured along the base surface) is 22 mm and most preferred maximum height of the cushioning component at the nose bridge position is approximately 24 mm.


Bottom Lip Region


As shown in FIG. 16g, the cross section at the bottom lip region BL may preferably be generally trapezoidal. The cross section at the bottom lip region BL may also be another other reasonable shape, such as generally rectangular, oval, octagonal etc. In addition, it is possible for the cross section at the bottom lip region to include a shape with generally rounded or curved corners. The cross section at the bottom lip region may also be an irregular shape. FIG. 25 demonstrates this feature in a cross section for the bottom lip region.


Preferably, in the embodiment depicted in FIG. 25, the apex 950 is skewed towards the centre of the mask, the outer side or surface of the cushioning component at the region that is adapted to contact the bottom lip region of the patient. The outer side has been divided into an upper and a lower portion, wherein the upper portion is at a reduced angle in respect to the lower portion. The apex 950 is adapted to rest or engage the cleft formed between the bottom lip of the patient and lower extremity of the chin. The upper portion is adapted to engage the patient's face at a position lower and extending away from the cleft. Thereby providing an increased sealing surface between: the patient's face at the location between the bottom lip and the lower extremity of the chin; and the outer side of the cushioning component.


As best shown in FIGS. 16g and 25, the patient contacting surface 940 is generally flat or has a larger radius r2 when compared to the nasal bridge region radius r1. This arrangement aids in comfort and increases the length of the sealing surface such that a better seal may be maintained.


In FIG. 25, the radius r2 at the apex of the cushion is preferably about 5 mm.


Alternatively, patient contacting surface 940 may have apex 950 that may first contacts the patients face and anchors the cushion in the dimple of the chin or curvature between the lower lip and chin region. Apex 950 may have a relatively small radius r2 when compared to that radius r2 shown in FIG. 16g. Radius r2 may be about 5 mm. Patient contacting surface 940 may also have a kink or inflexion 960 that may generally match the approximate curvature of the chin so as to rest the cushion on the chin to sealingly engage the cushion with the patient. This kink 960 also allows apex 950 to flex inwards towards the centre of the cushion, and outwards away from the centre of the cushion, so as to accommodate movement of the patient's chin or jaw. For example, it is possible for patients to drop their jaw during sleep, so in order to maintain a seal with the patient, the mask must be able to move with the patient's jaw. This arrangement further enables a greater fit range of patients, i.e. kink 960 may flex either inwards or outwards on a patient's jaw depending on the length and depth of their chin, other facial features etc.


Additionally, as shown in FIGS. 16g and 25, the internal wall 942 of the cushioning component is arranged substantially vertical or normal to the face of the patient in use as demonstrated by angle 2150. This arrangement reduces the likelihood of the foam cushioning component touching the patient's bottom lip when compressed in use, a problem that may occur for larger faces within each size range.


The preferred maximum width of the cushioning component as measured in respect of the base surface is generally about 35 mm in relation to the bottom lip region. The preferred maximum height of the cushioning component is generally about 26 mm in relation to the bottom lip region.


In FIG. 25, the angle formed between the outer side and base surface is approximately between 80-90 degrees; and the angle formed between the inner side and the base surface is approximately between 90 to 100 degrees. Preferably, the angle by which the outer side meets with the base surface is generally less than the angle formed between the inner side and the base surface.


Side of Nose Region


As shown in FIG. 16h, the cross section at the side nose SN is generally triangular. The cross section at the side nose region SN may also be another other reasonable shape, such as generally rectangular, oval, octagonal etc. In addition, it is possible for the cross section at the side nose region to include a shape with generally rounded or curved corners. The cross section at the side nose region may also be an irregular shape. FIGS. 21 and 22 show an alternative cross section for the side of nose region.



FIG. 16h shows a cross-section of the cushioning component in a side of nose region SN. Similar to the nasal bridge region NB as shown in FIG. 16g, the cross section is generally triangular. However the triangular cross section is skewed or biased towards the inner edge of the cushioning component. This arrangement aids with sealing because inner wall 944 abuts the side of the patient's nose in use, thereby increasing the sealing surface. This is similarly demonstrated in FIGS. 21 and 22.


Preferably, the outer side is longer than the inner side. Also preferably, the angle formed between the outer side and the base surface is generally less than the angle formed between the inner side and the base surface.


The most preferred maximum width of the side of nose region (as measured along the base surface) is 22 mm and most preferred maximum height of the cushioning component at the side of nose position is approximately 24 mm.


Cheek Region


As shown in FIG. 16i, the cross section at the cheeks C is generally trapezoidal or triangular. The cross section at the cheeks region C may also be another other reasonable shape, such as generally rectangular, oval, octagonal etc. In addition, it is possible for the cross section at the cheeks region to include a shape with generally rounded or curved corners. The cross section at the cheeks region may also be an irregular shape. FIGS. 23 and 24 show an alternative cross section for the cheek region.



FIG. 16i shows a cross-section of the cushioning component in a cheek region C. As illustrated, the contacting surface or apex 946 where the cushioning component contacts the patient's cheek is similar to that at the bottom lip region BL as shown in FIG. 16g. The cross section is generally triangular, and may have a smaller top surface 946 when compared to the top surface 940 of the bottom lip region BL. This arrangement aids sealing around the patient's cheeks in use and increases the comfort of the interfacing portion, while reducing the bulk of the interfacing portion at the cheek region C.


A similar arrangement is shown in FIGS. 23 and 24. However, as shown in FIG. 24, inflexion 950 changes the curvature of the side wall of the cushion so that it may hinge or bend inwards. This may increase the ability for the cushion to seal on the patient's face when in use.


Preferably, the outer side of cushioning component is longer than the inner side. Also preferably, the angle formed between the outer side and the base surface is generally less than the angle formed between the inner side and the base surface.


The most preferred maximum width of the cheek region (as measured along the base surface) is 23 mm and most preferred maximum height of the cushioning component at the cheek region is approximately 24 mm.


Additionally, when the clip portion is joined or mounted to the cushioning component, the apex of the cushion is additionally offset towards the centre or middle of the mask. In the described embodiments, the apex may be offset to the extent that it overhangs the point formed between the inner side and the base surface.


2.2.2 Nasal Mask



FIGS. 39 to 47 show an alternative embodiment of the present invention. Cushion component 4000 may be used as a nasal mask that only covers the nose of the patient in use, and is positioned on the nose bridge, side of nose, cheeks and or upper lip region and may not cover the patient's mouth.


Preferably, the cushioning component of the nasal mask shown in respect of these embodiments is preferably: 70-75 mm in length (when measured from the outer most edges of the base surface of the cushioning component); and the width of the cushioning component is approximately 75-80 mm.


Nasal Bridge Region, Side of Nose Region and Cheek Region


The nasal bridge region 4200, side of nose region 4300 and cheek region 4400 may be generally similar to that described above for a full face cushion.


The preferred height of the cushioning component at the region designated to correspond to the nasal bridge of the patient is approximately 22 mm. The height of the cushioning component at the position designated to meet the side of the nose is approximately 25-27 mm. The height of the cushioning component at the position designated to meet the patient's cheek regions is approximately 27 mm.


The preferred width of the cushioning component in the side of nose regions is typically about 20 mm. Whereas the preferred width of the cushioning component in the cheek regions is typically about 18 mm.


Upper Lip Region


As shown in FIGS. 39 and 41, cushion component 4000 may have an upper lip region 4100 that has a dip or region of reduced height (when viewed from a side view as shown in FIG. 41) relative to the height of other regions 4200. This feature may accommodate various upper lip regions of patients whilst avoiding accidental occlusion of the nares. The overall reduction in the amount of foam material may reduce the risks for patients.


The preferred width of the cushioning component in the upper lip region is typically about 16 mm. The width of the cushioning component in the upper lip region may be 10-20 mm. The width of the cushioning component in the upper lip region may be 15-20 mm. The width of the cushioning component in the upper lip region may be 12-20 mm. The width of the cushioning component in the upper lip region may be 10-15 mm. The width of the cushioning component in the upper lip region may be 10-18 mm. The width of the cushioning component in the upper lip region may be 10-14 mm.


The preferred height of the cushioning component at the region designated to correspond to the upper lip of the patient is approximately 18 mm. The height of the cushioning component in the upper lip region may be 10-20 mm. The height of the cushioning component in the upper lip region may be 10-25 mm. The height of the cushioning component in the upper lip region may be 15-20 mm. The height of the cushioning component in the upper lip region may be 16-23 mm.


Fit Range


Because of the wide range of sizes and shapes of different people's faces, it is a continual challenge for mask designers to determine the least number of mask shapes required to fit the broadest range of patients. In one ideal form, a single mask shape would fit all patients.


A mask assembly in accordance with the invention provides an improved fit range. This maybe preferably achieved by combining a more comfortable and compliant material with a more anatomically neutral geometry that seals against a wider range of facial anatomy for a given shape.


The versatility of a chosen cushion shape, and hence its fit range performance, is also enhanced by the ‘hovercraft’ behavior exhibited by the cushion. In this context the “hovercraft” behavior is generally defined by the air pressure in the cavity of the mask when the air pressure in cavity of the mask is greater than the outside environmental air pressure and thereby allows the mask to float on the face of the wearer. The pressure seal is preferably formed by the cushioning component. This feature may enhance the ease and speed of fitting the mask.


When pressurized with air the cushion material has extra extensibility compared to other known cushion materials. The soft flexible cells in the foam material effectively stretch when inflated allowing the material the freedom to enlarge. This allows the cushion material to have an extra dimension of conformability over other cushion materials known in the art e.g. silicone, by being able to expand and morph to facial anatomy when inflated with air pressure. This is, in part, also achieved by combining an expandable open-cellular structure in direct communication with the air that is providing the positive airway pressurization. It is the flow of air through the sealing material that forms a fine layer of pressurized air between the facial skin, and the flexible nature of the cushion material that enables this hovercraft effect, hence making it easier to fit to the face. The foam being less sticky than silicone also has a significant advantage in achieving an easy, fast and comfortable fit.


2.3 Method of Manufacturing


The following manufacturing techniques may be used to create a range of shapes and cross-sections as may be required for different facial shapes. Since the cushioning component is preferably made from unskinned foam, one or more cutting processes may be used to create the part, such cutting processes including die cutting, and/or machining, etc. Alternatively the cushioning component may be molded with measures taken in the process to minimize the skin on the foam component, or the skin being subsequently removed from the molded component in a post process e.g. machined. Preferably, the foam material used in the herein described embodiments may be an open and closed cell foam. The foam material used may be an open cell foam. The foam material used may be a closed cell foam.


2.3.1 Die Cutting


In the illustrated embodiment shown in FIGS. 4a-4g, both an inside surface and an outside surface of the foam cushion component 232 are die cut. This typically results in generally straight cut edges. The cushion in these embodiments may have a generally rectangular cross section, where the top surface is generally substantially parallel to the patient's face in use, and the inner and outer side surfaces are generally perpendicular to the patient's face in use. It may be possible to die cut the foam using additional processing steps to create a non-rectangular cross section, e.g. the use of shims. The die cutting of a cushion component then from a flat sheet of foam results in a flat backed cushion component which may subsequently take the shape of a clip that it is assembled to e.g. glued. The foam cushion is therefore deformed into its final intended shape.


To create a curved backed cushion, that for example matches the shape of a curved clip without stretching or deformation, the cushion component may be die cut from a foam sheet that is cut into a curved shape rather than a flat sheet. The curved sheets may be formed from a known process referred to as contour cutting, where a foam block is cut into curved sheets by being fed into an oscillating blade that changes position and orientation during the cutting process.


In addition to die cutting or in the alternative, the cushioning component, e.g., as shown in FIGS. 9a to 12f, may be cut into a three-dimensional shape or geometry using the techniques described in AU 2008904769 and AU 2008904778.



FIGS. 9a to 9d illustrate a foam-based interfacing structure 430 including a foam cushion component 432 and a clip portion 434. Outer wall 400 may include contours and curvature incorporated into the design. The inner, patient contacting wall (or orifice) 402 may be die cut as known in the art. Again, this typically results in straight cut edges (e.g., see FIGS. 9b and 9d).



FIGS. 10a to 10c illustrate a foam-based interfacing structure 330 including a foam cushion component 332 and a clip portion 334, wherein the cushion component 332 includes localized regions with curvature or ridges, e.g., ridges 350 along cheek regions of the cushion component, a curvature 352 along the nasal bridge region of the cushion component, etc. In addition, the cushion component 332 is contoured along the chin region of the cushion component. The straight die cut inner and outer edges remain perpendicular to the patient's face in use similar to the previous embodiment.



FIGS. 11a to 11c illustrate a foam-based interfacing structure 530 where a localized region 552 in the cushion component 532 at the nasal bridge has been raised, e.g., formed with a curved surface.



FIGS. 12a to 12f illustrate another embodiment in which a foam-based interfacing structure 630 including a foam cushion component 632 and a clip portion 634, wherein the foam cushion component 632 includes a slab of foam that is cut using methods known in the art. This process may be repeated in order to cut the outer wall 600 of the cushion component and then the inner, patient contacting wall (or orifice) 602 of the cushion component.


3. Clip Component

3.1 Material


The cushion-to-frame component may be made from a material that has greater structural integrity than the cushioning component. In a preferred embodiment the clip is made from polyurethane foam that has higher hardness, higher density, and lower permeability than the foam used for the cushioning component. The clip/cushion-to-frame component may be formed in a mould giving rise to a harder, denser, lower permeability foam having a skin. In an alternatively preferred embodiment, the clip may be constructed of a non-foamed polymer, for example (but not limited to), nylon, polycarbonate, polypropylene.


Preferably, the clip portion or clip component may be of reduced hardness or increased flexibility in comparison to the frame portion of the mask to which it is to connected or secured with.


3.2 Shape


The clip 934 is shown generally in FIG. 13, and in more detail in FIGS. 15a-15e. The clip 934 is generally shaped in order to align with the frame. However, the general curvature of the clip 934 can be altered to suit the frame to which it is to be fitted. The general curvature of the clip may also be used to shape the cushion component. Since the cushion component is made from compliant foam, it will readily adapt to the shape of the clip when joined together. An example of where this may be an advantage is when the cushion component is made to have a flat back (from a flat foam sheet as described previously) and is given its final shape by assembly (e.g. glued) to a clip that gives the cushion its intended shape (e.g. curved).


The clip may also be made flat. The cushion can therefore also be made with a flat back to match the clip. The overall intended shape of the interfacing structure (combination of clip and cushion) can therefore be alternatively achieved by the flat clip and cushion being deformed and retained into a curved frame. This embodiment allows clip to be manufactured flat which can have several advantages including ease of handling and alignment during manufacture, packaging and transportation. The clip can therefore be formed by alternative methods e.g. die cutting from flat sheet material.


The clip may also be made curved. This may be achieved by several means including molding directly into a curved shape, die cutting from curved (contour cut) sheet, or heat forming a flat clip die cut from a thermoformable material. Having the clip curved allows ease of alignment and assembly to a curved frame, as well as giving the cushion a curved shape if the cushion is made from a process that results in it having a flat back.


In a preferred embodiment the clip is made from molded polyurethane. The cushion contacting surface 935 is generally smooth so that it can continuously join and seal to the underside of the cushion. Cushion contacting surface 935 has a lip 935a to enable alignment of the clip to the frame.


Frame contacting surface 937 has three alignment tabs 938 protruding from its surface that engage with the frame. There may be any number of alignment tabs 938 to aid the patient in aligning the interface structure with the anchoring structure. It should also be appreciated that the clip need not have alignment tabs 938 to engage the clip with the frame.


The clip may also be made to incorporate features that engage the frame to aid retention of the interfacing structure to the frame. Examples include, but are not limited to, surface roughening, ribs, notches, snaps etc.


3.3 Method of Manufacturing


The clip component may be separately formed as will be now described, or insert molded as will be described later in this specification.


By way of example, FIGS. 18a to 18c illustrate a tool to mold a clip portion by itself, where the clip portion may subsequently be attached to the cushion component, e.g., by an adhesive or simply adhesion between the clip and cushion component. As illustrated, the tool includes a top half 1560 and a bottom half 1565 which are adapted to be joined together to form the clip portion. As shown in FIG. 18b, the tool provides a curved parting line PL between the top and bottom halves 1560, 1565.


The bottom half 1565 includes a cavity 1567 adapted to receive the material (e.g., foaming mixture) that will form the clip portion. Also, the center section 1568 of the bottom half 1565 accommodates a separate insert that acts as a manual ejection feature after molding. The top half 1560 provides a surface 1562 that will form the side of the clip portion for interfacing or joining with the cushion component.


The top and bottom halves 1560, 1565 of the tool are constructed and/or arranged to facilitate demolding of the clip portion from the tool so that the clip portion will not adhere to the tool. For example, the top and bottom halves 1560, 1565 may be constructed of a material from which the mold material (e.g., foaming mixture) may be removed (e.g., high density polypropylene, silicone). Alternatively, a demolding agent (e.g., wax) may be provided to the top and bottom halves to facilitate demolding.


An alternative demolding aid may be a release film that lines the tool and releases from the clip material easily after molding. In a preferred embodiment the release film may double, in whole or in part, as the packaging for the interfacing structure such that the product leaves the molding process already packaged. In another embodiment the clip includes a tab at one or a number of locations that facilitates gripping of the part for demolding during the manufacturing process. This tab feature may also double as an alignment feature for assembly and a gripping feature for disassembly for the user of the mask assembly.


In another embodiment the clip may include a tab feature that includes an end of life indicator for the interfacing structure.


4. Sub-Assembly

4.1 Relative position


In accordance with an embodiment of the invention, a range of different arrangements of clip portions and cushion components may be provided. For example, the width of the clip portion may preferably match or be less than the maximum width of the cushion component, the width of the cross section of clip portion may be less than the width of the cross section of the cushion component. In these different configurations with different relative widths, the clip portion provides different forms of support to the cushion component.


Wherein the width of the cross section of the clip portion is less than the width of the cross section of cushion component, the clip portion and cushion component may be arranged such that (i) the outer perimeter of the clip portion and cushion component align (hides hardness of clip portion and provides desired freedom of movement in the cushion component), (ii) the inner perimeter of the clip portion and the cushion component align, or (iii) neither the inner or outer perimeter of the clip portion and the cushion component align.


Similarly, wherein the width of the clip portion is greater than the width of the cushion component, the clip portion and cushion component may be arranged such that (i) the outer perimeter of the clip portion and cushion component align, (ii) the inner perimeter of the clip portion and cushion component align, or (iii) neither the inner or outer perimeter of the clip portion and the cushion component align.


When the width of the clip portion is less than the width of the cushion component and the outer perimeter of the clip portion aligns with the cushion component, the cushion component may preferably be more able to flex in regions or directions not having a clip portion next to it than in regions having a clip portion adjacent to it or supporting it. For example, where the cushion component overhangs the clip portion, that overhanging region of the cushion component has more freedom to move. This arrangement can be more comfortable and more able to adapt to different geometries of a person, and provide the correct vectors to seal the cushion component against the face.


Preferably, the clip portion is to be joined to a cushioning component by a base surface of the cushioning component. It may also be preferably to arrange the clip portion to support the external extremity (relative to the circumference of the mask) of the base surface and to have no or little support inner extremity of the base surface.


When used as part of a respiratory mask, it may be preferable that the inner portion of the cushion component overhang the clip portion. In this arrangement in use, the face of the patient may engage with an unsupported inner edge of the softer cushion component causing it to bend and conform to the individual patient's shape. When the mask engages a patient's face, the cushioning component may roll inwards towards the centre of the mask when pressure is applied on the mask towards the patient's face.



FIG. 7a shows an elevation view detail from the frame side of the interfacing structure 230 shown in FIG. 4e in a nasal bridge region. As shown in cross-section in FIG. 7b, it is apparent that the width w2 of the clip portion 234 is less than the width w1 of the cushion component 232 and that the outer perimeter of the clip portion 234 and the cushion component 232 are aligned. An advantage of this arrangement is illustrated in FIG. 7c where in use the nose is able to push the inner perimeter of the cushion component 232 in the direction shown by the arrow, in a cantilever manner as well as compressing. FIG. 8 is a cross-section showing the clip portion 234 of the interfacing structure 230 received within the channel 22 of a mask frame 20.


This arrangement is in contrast to prior art cushions (such as the Lifecare™ mask shown in FIGS. 6a and 6b) where the inner perimeter of the cushion C abuts the frame F, and hence it is not free to move inwardly and can only compress.



FIGS. 26-32 show an alternative embodiment of the present invention. FIG. 26 shows the cross sections later shown in FIGS. 27-32. Cushion component 3232 may be attached to clip component 3234. Cushion component 3232 may be similar to that shown in FIGS. 19-25. Clip component 3234 may have upper surface 3500 that attaches to cushion component 3232. Upper surface 3500 may be generally horizontal when in use or assembled, as shown in FIGS. 27, 28, and 29. In addition, this may position the tangent to apex 3600 of the cushion component 3232 generally parallel to upper surface 3500. Alternatively, upper surface 3500 may be generally curved or angled inwards towards the inner portion of the cushion so as to angle the cushion more towards the centre of the patient's face, as shown in FIGS. 30, 31, and 32. Therefore, tangent to apex 3600 may not be parallel to upper surface 3500. In an embodiment, the upper surface 3500 may be angled in one or more selected regions, e.g., lower cheek or chin regions to fit patients with more narrow, shallow faces (see FIGS. 30-32).


In an embodiment, as shown in FIGS. 27-32, the outer edge of the cushion component may slightly overhang (e.g., 1 mm overhang) the clip component, e.g., for manufacturability.


4.2 Glue


The two layers (i.e., the cushion component and the clip portion) may be adhered to one another using polyurethane hot melt glue or cyanoacrylate.


In alternate embodiments (not shown in Figures) the cushioning portion may be directly glued onto the frame.


4.3 Insert Molding


In a manufacturing process according to an embodiment of the present invention, insert molding may be used to assemble the cushioning component to the cushion-to-frame component. An advantage of this approach include lower cost when compared to other processes such as gluing.



FIGS. 17a to 17h illustrate a tool and manufacturing process for manufacturing an interfacing structure according to an embodiment of the present invention.


As best shown in FIG. 17a, the tool includes a first portion 1060 adapted to receive the cushioning component that may be cut from foam slabstock and a second portion 1065 adapted to receive the foaming mixture that will form the cushion-to-frame component.


The first portion 1060 of the tool may allow a vacuum to be applied to the cushioning component to retain it in position. For example, as shown in FIG. 17a, the walls of the cavity that receive the cushioning component include a plurality of orifices 1062, and a vacuum is applied to an opening 1063 in the side wall of the first portion 1060 so that the cushioning component may be drawn into the cavity. The first portion 1060 may be sized to provide an interference fit with the cushioning component.


The first and second portions 1060, 1065 of the tool are arranged so that there will be a region of contact between the cushioning component and the cushion-to-frame component such that they will adhere to one another.


At least a second portion of the tool is constructed and/or arranged to facilitate demolding of the cushion-to-frame component that would otherwise adhere to the tool. Preferably, this is achieved by using a tool constructed of a material from which the foam may be removed (e.g., high density polypropylene, silicone). Alternatively, steel or aluminum tools may be used, provided an appropriate de-molding agent can be used, such as wax (e.g., agent that does not present biocompatibility issues).


In the illustrated embodiment as best shown in FIG. 17a, the second portion 1065 includes three parts that are removably attached to one another, i.e., an inner portion 1066(1), and outer portion 1066(2), and a ring portion 1066(3).


An insert molding manufacturing process according to an embodiment of the invention will now be described in greater detail.



FIG. 17a illustrates the first and second portions 1060, 1065 of the tool separated from one another. In FIGS. 17b and 17c, the cushioning component 1032 is placed in the first portion 1060 of the tool. The cushioning component 1032 may be held in place in the first portion 1060 by a vacuum and may impart curvature on the cushioning component via the vacuum. This may be necessary if the cushion is made from a process that gives is a flat backed geometry. Placement of the cushioning component 1032 may be manual or automated. For example, the cushioning component 1032 may be sucked into the first portion 1060 using the vacuum.


In FIG. 17d, a mixture of polyurethane (e.g. foam or elastomer) is prepared to form the cushion-to-frame component 1034 and the high-intensity mix is poured into the second portion 1065 of the tool. Pouring of the mix for the cushion-to-frame component 1034 may be manual or automated. If the cushion-to-frame component 1034 is made from a foam the cavity of the second portion 1065 will only be partly filled (e.g., 25%) and during the foaming process it will expand to fill the space and come into contact with the cushioning component where it will adhere.


In FIG. 17e, the first and second portions 1060, 1065 of the tool are clamped together or closed to allow the cushion-to-frame component foaming reaction to proceed in the tool. That is, the foam for the cushion-to-frame component 1034 can rise up and chemically bond or adhere to the foam cushioning component 1032. The choice of clip material may enhance the bonding or adhesion process. In a preferred embodiment both the clip and the cushion are made from polyurethane material for ideal bond integrity between the two components. Additionally, should the cushion component have a regular, uniform, rough, irregular or non-uniform cell structure, the clip component may infuse into gaps in the cell structure of the cushion component, forming small mechanical bonds between the components.


When the cushion-to-frame component 1034 has cured, the vacuum first portion and second portion are separated as shown in FIG. 17f. In FIG. 17g, the ring portion 1066(3) at the bottom of the second portion 1065 is removed and the inner portion 1066(1) is ejected to demold the cushion-to-frame component 1034. FIG. 17h shows the resulting interfacing structure 1030 removed from the tool with the cushioning component 1032 adhered to the cushion-to-frame component 1034. In a preferred embodiment the cushion component is originally flat when vacuum inserted into the top half of the tool and is bonded to a curved clip during the insert molding process. The resultant interfacing structure then assumes an intended curved shape.


In an alternative embodiment the cushion and clip are made flat but the cushion is made with sufficient depth to not require curvature to suitably adapt to the face when worn; but rather suitably deforms to the shape of the face due to the softness and depth of the cushion foam.


In another alternative arrangement, a film may be added to the second portion of the tool prior to the addition of the foaming mixture. This film may be structured to facilitate removal of the otherwise adhering cushion-to-frame component. The film may be used to form packaging for the interfacing structure.


In an embodiment, the clip portion of the interfacing structure may be constructed from more rigid and denser foam than the cushion component. For example, the clip portion may be formed from nitrogen blown polyethylene, or some other biocompatible foam having a fine cell-structure. Alternatively, the clip portion could be made from some other polymer or rubber. In an embodiment, the clip portion is adapted to form a cushion-to-frame engagement mechanism and to form a structural support for the cushion component.


Preferably, the cushioning component is less rigid, less stiff or more flexible than the clip portion, which is in turn less rigid, less stiff or more flexible than the frame of the mask. Preferably, the frame gives shape to the mask interfacing structure, wherein the interfacing structure is relatively flexible and less rigid, overall than the frame. This feature adds comfort and also allows the interfacing structure to be easily replaced by the patient or user. Further improvements to the interfacing structure may be made to adapt the shape and configuration to be disposable.


For example, FIG. 13 shows a clip portion 734 including a side 735 for interfacing with a foam-based cushion component and a side 737 for interfacing with a mask frame. In this embodiment, the clip portion 734 is constructed of a skinned foam and may be formed by molding. The foam of the clip portion 734 may be harder or more dense than the foam of the cushion component. Alternatively, the more dense or harder foam may be formed by cutting, e.g., die cutting, machining, and/or the methods set forth in AU 2008904769 and AU 2008904778.


This arrangement provides a one piece interfacing structure with a cushion component adapted to engage the patient's face and a clip portion adapted to interface with the mask frame.


In one form, a mask system may be provided that includes at least two different forms of interfacing structure chosen from the set of foam-based cushion, silicone-based cushion, and gel-based cushion.



FIGS. 14a to 16i illustrate an interfacing structure 930 including a cushion component 932 and a cushion-to-frame component or clip portion 934 provided to the cushioning component 932. FIGS. 14a to 14f show the cushioning component 932 attached to the cushion-to-frame component 934, FIGS. 15a to 15e are isolated views of the cushion-to-frame component 934, and FIGS. 16a to 16i are isolated views of the cushioning component 932.


As shown in FIGS. 14a to 15e, the cushion-to-frame component 934 includes a side 935 for interfacing with the cushioning component 932 and a side 937 for interfacing with a mask frame. The side 937 includes protrusions 938 to facilitate and/or enhance attachment to the mask frame.


5. Assembling the Frame and Interfacing Structure

The interfacing structure is constructed as described above and arranged for removable interconnection with the rest of the apparatus, for example a respiratory mask.


The ability to removably connect the interfacing structure enables one to replace the interfacing structure should it become soiled, damaged, uncomfortable or otherwise aged as a result of usage. It also facilitates trial or testing of different arrays of interfacing structures which are selected on different patients facial types or features (e.g., narrower face, longer nose, or longer chin, etc.). One form of interfacing structure, for example a foam-based interfacing structure, may be used as a form of “training” system to allow a person to become accustomed to the sensation of wearing and using a mask. A foam-cushion based mask may provide an initially more appealing and comfortable surface for a new patient than a gel or silicone-based cushion. The patient may subsequently switch from the foam-based cushion to a silicone or gel based cushion. In this way, the patient may be more likely to adhere to therapy because they are used to the very soft comfortable feeling of foam.


When applied to respiratory equipment, the interfacing structure is adapted for connection with a mask frame. In use, a seal is formed between the interfacing structure and the frame. This arrangement could be used for both nasal and full-face masks. The seal between the frame and interfacing structure may seal better wherein the clip portion is less rigid or more flexible than the frame.


For example, FIG. 1 illustrates a mask 10 including a mask frame 20 a foam-based interfacing structure 30 provided to the mask frame 20. As illustrated, the foam-based interfacing structure 30 provides a foam cushion component 32 adapted to contact the patient's face in use. In this embodiment, the foam-based interfacing structure 30 is adapted for use with an existing mask (e.g., ResMed's Mirage Quattro mask), which allows the patient to switch from the foam-based interfacing structure 30 to the mask's existing silicone-based cushion if desired.



FIGS. 4a to 4g show a foam-based interfacing structure 230 according to an embodiment of the invention. As illustrated, the interfacing structure 230 includes a cushion component or face-contacting portion 232 and a clip portion 234 provided to the cushion component 232. In this embodiment, the clip portion 234 is adapted for an interference fit with a mask frame, and the width of the clip portion 234 is narrower than the width of the cushion component 232 (e.g., see FIGS. 4e and 4g).


5.1 Cushion-to-Frame Engagement Mechanisms


According to an aspect of the invention, the cushion-to-frame engagement and connection mechanism provided by the clip portion may include a channel-type engagement or rib-type engagement.


As shown in FIG. 2, the channel-type engagement includes a foam clip portion 34 that is adapted to be received within the channel 22 of a mask frame 20 with an interference fit. The foam clip portion 34 extends around the entire perimeter of the interfacing structure so as to form a seal and retention with the mask frame.


As shown in FIGS. 3a to 3c, the rib-type engagement includes a foam clip portion 34 with one or more slots 38 to receive inner and/or outer ribs 23, 24 of the mask frame 20. For example, the slot to rib engagement may provide an inner frame rib engagement (see FIG. 3a), an outer frame rib engagement (see FIG. 3b), or an inner and outer frame rib engagement (see FIG. 3c). This arrangement provides a broader base of support for the sealing foam.



FIGS. 5a and 5b illustrate a foam-based interfacing structure 830 including a foam cushion component 832 and a clip portion 834, and FIG. 5c illustrates the interfacing structure 830 provided to a mask frame 20. As shown in FIGS. 5a and 5b, the clip portion 834 includes a slot 838 adapted to receive a rib of the mask frame 20. Also, providing a wider clip portion 834 allows more stiffness and structural integrity to be provided to the clip portion, making the clip portion easier to assemble to the mask frame.


When structured to form an interference fit with the mask frame, the clip portion may have the following properties: appropriate rigidity (e.g., less than that of the frame and in one form more rigid than the foam cushion component); non-porous; and/or low compression set (the amount of deformation expressed as a percentage of original dimensions) which a material retains after compressive stress is released (in this way, the clip portion maintains its retention force during its usage life).


Additionally, the clip portion may include an additional extension (not shown) that extends beyond the outer extremity of the frame which is adapted to be gripped by the patient for easier removal of the interfacing structure. Preferably, this extension would be positioned in a region that is easy for the patient to grip such as the nasal bridge of the mask. Preferably, the extension will be small enough not to impede vision of the user or to affect the overall efficiency or seal of the mask. Preferable, the extension may function as a finger grip for the patient to remove or replace the interfacing structure, when desired.



FIGS. 50-1 to 57-2 illustrate alternative mechanisms for attaching the clip portion to the frame. In FIGS. 50-1 and 50-1, the clip portion 5034 is in the form of a microcellular polyurethane clip adapted to engage within the frame channel 5022 with an interference fit. In FIGS. 51-1 and 51-2, the clip portion 5034 is in the form of a flexible plastic clip (e.g., Hytrel, TPE) adapted to engage the frame channel 5022 with a snap fit. The clip portion also includes a lip seal 5035 adapted to engage the channel wall. In FIGS. 52-2 and 52-2, the clip portion 5034 is in the form of a flexible plastic clip adapted to engage the frame channel 5022 with a snap fit. The clip portion also includes a sealing element 5035 (thermoplastic elastomer that may be over molded on to the clip portion) adapted to engage the channel wall. In FIGS. 53-1 and 53-2, the clip portion 5034 is in the form of a polyurethane clip adapted to engage within the frame channel 5022 with an interference fit. The clip portion also includes a flexible plastic clip 5036 (assembled to the polyurethane clip) adapted to engage the frame channel with a snap fit. In FIGS. 54-1 and 54-2, the clip portion 5034 is in the form of a polyurethane clip adapted to engage within the frame channel 5022 with an interference fit. The clip portion also includes a flexible plastic clip 5036 (glued to the polyurethane clip) adapted to engage the frame channel with a snap fit. In FIGS. 55-1 and 55-2, the clip portion 5034 includes a flexible plastic clip adapted to engage the frame channel 5022 with a snap fit or other fitting means e.g. interference fit. In addition, the clip is contoured such that the clip also engages the channel wall with an interference fit. In FIGS. 56-1 and 56-2, the clip portion 5034 includes a flexible plastic clip adapted to engage the frame channel with a snap fit. The clip portion also includes a foam element 5037 adapted to cover the clip. In FIGS. 57-1 and 57-2, the clip portion 5034 includes a polyurethane clip (attached to cushion component by plastic element 5038) adapted to engage the frame channel 5022 with a snap fit. The frame channel includes a plastic extension 5023 adapted to engage the clip. This arrangement allows replacement of the cushion component without the need to change the clip portion.


6. Exemplary Materials and Properties

The following provides exemplary materials and properties of the cushion component and clip portion.


6.1 Cushion Component


In an embodiment, the cushion component may be made from polyurethane, be resistance to hydrolysis and/or resistant to microbial attack.


In an embodiment, the cushion component may be air permeable. In an embodiment, the cushion component may not be air permeable.


In an embodiment, the cushion component may be able to maintain its air permeability over a period of use.


Preferably, the cushion component may not emit harmful or odorous volatiles or particulates.


Preferably, the cushion component may be coloured and this colour may not fade.



FIG. 48 is a chart showing exemplary material properties for the cushion component.


In one example, properties of the foam cushion component may include: density (relates to other foam properties and affects cost and weight of the cushion, e.g., higher density can reduce air permeability and higher density can increase hardness); air permeability (flow of air through cushion contributes to total mask flow characteristic of the mask which may affect compatibility with PAP devices); hardness (affects comfort and sealing performance); tear resistance (contributes to durability); tensile strength (contributes to durability); and/or tensile stiffness (resists the deforming effects of positive air pressure inside the mask).


6.2 Clip Portion



FIG. 49 is a chart showing exemplary material properties for the clip portion.


In one example, properties of the foam clip portion may include: density (affects weight); air permeability (permeability of the foam itself may not be critical if it is molded with a skin that renders it impermeable); hardness (soft and flexible enough to assemble to the frame with an interference fit and seal against the frame); elasticity/viscoelasticity (soft and flexible enough to assemble to the frame with an interference fit and seal against the frame); and/or compression set (should not deform over time to ensure easy assembly/retention).


6.3 Testing Methods


The following provides exemplary testing methods for determining material properties.


6.3.1 Air Permeability


Air permeability is defined as “the rate of air flowing through a foam sample (in L/min)”.


This test measures the flow through a regular shape with a constant cross section, in a manner analogous to a cushion in real use. In the example of FIG. 60-1, the test specimen is an annulus of foam, about 30 mm thick. The circular shape ensures that pressure is evenly distributed and the foam inflates uniformly.


The foam sample is cut normal to cell rise direction as shown in FIG. 60-4.


The wall section of the foam specimen may be rectangular (see FIG. 60-2), but it is possible for the wall section to have a concave outer surface and a convex inner surface (see FIG. 60-3).


The annular foam sample is held at a defined height between two plates in a Universal Test Machine (e.g., Instron). Air at a given pressure is directed into the centre of the annulus and flows out through the foam. The air flow rate and reaction force of the foam against the plates may be measured. FIG. 60-5 is a schematic of the test set up.


As shown in FIGS. 60-6, 60-7, and 60-8, the test jig used to hold the foam consists of: an aluminum base plate that locates the foam and seals against the flat bottom surface of foam annulus; an air inlet and pressure port in the centre of the base plate; a clear polycarbonate top plate that seals against the flat bottom surface of foam annulus and allows observation of the test sample; and a part glued to the top plate to connect with a load cell attachment on the Universal Testing Machine (UTM).


Once set up, attach the top plate to the crosshead of the UTM, zero the load cell of the UTM.


Zero the displacement of the UTM at the uncompressed height of the foam sample, i.e., 30 mm above the base plate sealing surface.


If there is variation of 1 mm or more in the thickness of the samples, then for each sample: (i) assemble the foam sample into the test jig; (ii) lower the crosshead just until a positive force is read on the UTM, e.g., 0.2 N; and (iii) zero the displacement.


Lower the crosshead at 50±20 mm/min until 40% compression displacement is reached.


Immediately record the reaction force, at 0 cmH2O.


Wait 60 seconds and again record the force.


Immediately but gradually adjust the flow generator to 4 cmH2O (and immediately record force and flow rate.


Wait 60 seconds and again record the force and flow rate.


Repeat steps 7 and 8 for 12 cmH2O and 20 cmH2O.


6.3.2 Hardness


Hardness is defines as “force required to indent a test piece of foam to a stated percentage of its original thickness”.


Hardness may be tested using an IDM Universal Test Machine, or equivalent (e.g., see circular flat indenter of FIG. 61)


If applicable, precondition the foam as specified in AS 2282.2-1999.


Test the foam according to AS 2282.8-1999 Method A—Indentation force on deflection test.


Report IF40, the reaction force at 40% compression after 60 seconds indentation, H60s.


Also report the reaction force at 40% compression after 2 seconds indentation, H2s.


Report the sag factor or support factor, i.e., the ratio of 65% to 25% IFD value.


6.3.3 Tensile Strength


Tensile strength may be measured using an IDM Universal Test Machine, or equivalent. See FIG. 62-1.


Test both directions, i.e., parallel to and normal to the direction of cell rise.


Apply the following deviations from AS 2282.6-1999:


Do not reject test pieces that break outside the gauge length.


Record whether the test piece did break, did not break or came out of the jaws before maximum elongation was reached.


Three test pieces may be acceptable if the results are consistent (no individual value deviates more than 20% from the mean of the three values).


Select a typical or representative results curve by inspecting the graphs. Select a suitably linear region near the start of the curve. (The start of the curve is more representative of real use than an extremely stretched region and also ensures the result is not affected by the test sample sliding out of the gripping jaws.)


Calculate the change in force over a distance of at least 25 mm and divide by the distance to obtain the stiffness value in N/mm.


For example, the curve in FIG. 62-2 is most linear near the start of the curve, between 25 mm and 50 mm. Stiffness was calculated as follows.

ktensile=ΔF/Δx=(F50 mm−F25 mm)/(50−25)

6.3.4 Tear Resistance


Tear resistance is defined as the force required to propagate a tear in a pre-cut sample. See FIG. 63-1.


Test according to AS 2282.7-1999 with the following parameters:


The speed of separation of the jaws holding the test piece shall be 200 mm/min.


Test all three directions defined in FIGS. 63-2, 63-3, and 63-4. Test and report the tear resistance results (at) for each direction separately.


Apply the following deviations from AS 2282.7-1999:


Do not use a knife or blade to assist the direction of tear. Allow the foam to tear naturally.


It may not be possible to tear a 50 mm length of foam. Tear as far as possible up to 50 mm.


Total Mask Flow


This test measures the flow through only the foam cushion, by blocking the mask vent all other leak paths. See FIG. 64.


The cushion is compressed by 40% of its 30 mm thickness, i.e., 12 mm.


7. Other Features

In an embodiment, a mask frame may be integrally molded or formed with the cushion-to-frame component 1034. For example, the second portion 1065 of the tool may be structured to mold the cushion-to-frame component together with the mask frame.


In the illustrated embodiment, a polyurethane foam cushioning component is provided to a polyurethane foam or polyurethane elastomer cushion-to-frame component. In an alternative embodiment, one or both of the components may be constructed of a gel material. For example, both components may be constructed of gel, the cushioning component may be constructed of gel and the cushion-to-frame component may be constructed of foam, or the cushioning component may be constructed of foam and the cushion-to-frame component may be constructed of gel.


While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. For example the cutting techniques used for the cushioning component may also be used for the clip component, or the interfacing structure. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, bariatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.

Claims
  • 1. A respiratory mask to provide a supply of pressurized air to the entrance of the airways of a patient for treatment of sleep disordered breathing, comprising: a frame; andan interfacing structure, the interfacing structure comprising a connection portion joined to a cushioning component, the connection portion being of reduced hardness or increased flexibility with respect to the frame, the cushioning component being at least partially constructed from a foam material and including a patient-contacting side configured to directly engage and form a seal with a region of the patient's face in the vicinity of an entrance to the patient's airways,wherein an interior of the interfacing structure at least partially forms a cavity to receive at least a portion of the patient's nose in use,wherein an upper surface of the connection portion is joined directly to a base surface of the cushioning component, the upper surface being a top, most outwardly protruded surface of the connection portion in a direction towards the cushioning component, and the base surface being disposed on an underside of the cushioning component, andwherein at least one of the following parameters of the interfacing structure varies around a perimeter of the interfacing structure: 1) an amount of offset between an inner edge of the upper surface of the connection portion and an inner edge of the base surface of the cushioning component; and2) in a cross-sectional profile of the interfacing structure, an angle of the upper surface of the connection portion, when the respiratory mask is not worn by the patient, the upper surface extending from the inner edge of the upper surface radially outwardly towards an outer radial extent of the upper surface.
  • 2. The respiratory mask of claim 1, wherein the variation of the parameters around the perimeter of the interfacing structure impart a respective variation in a roll-in effect of the cushioning component.
  • 3. The respiratory mask of claim 1, wherein the upper surface is angled inwardly towards an inner portion of the mask in at least one region of the cushioning component to assist in a rolling-in effect of the cushioning component when the mask is worn.
  • 4. The respiratory mask of claim 1, wherein the foam of the cushioning component has a density in the range of 40-70 kg/m3, and an IFD hardness measured in the range of 70 to 160N at 40% compression using the AS 2282.8 testing standard.
  • 5. The respiratory mask of claim 1, wherein the foam of the cushioning component has a tear resistance in the range of 100-500 N/m, and an air permeability in the range of 1 to 16 L/min at 40% compression 20 cmH2O.
  • 6. The respiratory mask of claim 1, wherein the connection portion is configured to directly connect to the frame, the connection portion being arranged to support the foam of the cushioning component and connect the cushioning component to the frame.
  • 7. The respiratory mask of claim 1, wherein, in at least one region of the cushioning component, the inner edge of the upper surface of the connection portion is offset outwardly from the inner edge of the base surface of the cushioning component, leaving an inner portion of the cushioning component unsupported, to facilitate a rolling-in effect.
  • 8. The respiratory mask of claim 7, wherein the amount of offset between the inner edge of the upper surface of the connection portion and the inner edge of the base surface of the cushioning component varies along the at least one region of the cushioning component.
  • 9. The respiratory mask of claim 7, wherein, in the at least one region of the cushioning component having the offset, a width of the connection portion is less than a width of the cushioning component such that the cushioning component overhangs the connection portion causing the inner portion of the cushioning component to be unsupported.
  • 10. The respiratory mask of claim 1, wherein the connection portion comprises a material that has different material properties than the foam of the cushioning component.
  • 11. The respiratory mask of claim 10, wherein the connection portion comprises a foam material that is denser than the foam of the cushioning component.
  • 12. The respiratory mask of claim 11, wherein the foam of the connection portion has an air permeability in the range of 0-5 L/m2/s.
  • 13. The respiratory mask of claim 12, wherein the foam of the connection portion has a density in the range of 100-500 kg/m3.
  • 14. The respiratory mask of claim 13, wherein the foam of the connection portion has an IFD hardness at 40% compression in the range of 10 to 100N.
  • 15. The respiratory mask of claim 1, wherein, in a cross-sectional view, the cushioning component has a rectangular, trapezoidal or triangular shape.
  • 16. The respiratory mask of claim 1, wherein the connection portion is integrally formed with the frame.
  • 17. The respiratory mask of claim 1, wherein the connection portion is integrally formed with the cushioning component.
  • 18. The respiratory mask of claim 1, wherein the cushioning component has a triangular cross-section and includes: an inner side facing the center of the mask;an outer side facing away from the center of the mask; anda base side, which includes the base surface, that is arranged to face the upper surface of the connection portion.
  • 19. The respiratory mask of claim 18, wherein, in a cross-sectional view, a length of the outer side of the cushioning component is greater than a length of the inner side of the cushioning component, to facilitate the rolling-in effect.
  • 20. The respiratory mask of claim 18, wherein the outer side further comprises at least an upper portion and a lower portion, wherein the upper portion extends at a reduced angle in comparison to the lower portion.
  • 21. The respiratory mask of claim 1, wherein a portion of the cushioning component has an outer surface which has positive curvature in two directions thus forming at least a partial dome.
  • 22. The respiratory mask of claim 1, wherein an upper surface of the connection portion is disposed at an angle in at least a cheek region and/or a lip region of the interfacing structure.
  • 23. The respiratory mask of claim 1, wherein the cushioning component in a nasal bridge region has a raised profile relative to an adjacent cheek region of the cushioning component.
  • 24. The respiratory mask of claim 1, wherein the frame is more rigid than the connection portion and the connection portion is more rigid than the cushioning component.
  • 25. The respiratory mask of claim 1, wherein the connection portion is configured to directly connect to the frame, the connection portion being arranged to support the foam of the cushioning component and connect the cushioning component to the frame, wherein, in at least one region of the cushioning component, the inner edge of the upper surface of the connection portion is offset outwardly from the inner edge of the base surface of the cushioning component, leaving an inner portion of the cushioning component unsupported, to facilitate a rolling-in effect,wherein the amount of offset between the inner edge of the upper surface of the connection portion and the inner edge of the base surface of the cushioning component varies along the at least one region of the cushioning component,wherein, in the at least one region of the cushioning component having the offset, a width of the connection portion is less than a width of the cushioning component such that the cushioning component overhangs the connection portion causing the inner portion of the cushioning component to be unsupported, andwherein the connection portion comprises a material that has different material properties than the foam of the cushioning component.
  • 26. The respiratory mask of claim 25, wherein the upper surface is angled inwardly towards an inner portion of the mask in at least one region of the cushioning component to assist in a rolling-in effect of the cushioning component when the mask is worn, wherein the cushioning component has a triangular cross-section and includes: an inner side facing the center of the mask;an outer side facing away from the center of the mask; anda base side, which includes the base surface, that is arranged to face the upper surface of the connection portion,wherein, in a cross-sectional view, a length of the outer side of the cushioning component is greater than a length of the inner side of the cushioning component, to facilitate the rolling-in effect,wherein a cross-sectional profile of the cushioning component varies along the perimeter of the interfacing structure, andwherein a cross-sectional profile of the connection portion varies along the perimeter of the interfacing structure.
  • 27. The respiratory mask of claim 1, wherein each the following parameters of the interfacing structure varies around the perimeter of the interfacing structure: 1) the amount of offset between the inner edge of the upper surface of the connection portion and the inner edge of the base surface of the cushioning component; and2) in the cross-sectional profile of the interfacing structure, the angle of the upper surface of the connection portion, when the respiratory mask is not worn by the patient.
  • 28. The respiratory mask of claim 27, wherein at least one of the further following parameters of the interfacing structure varies around the perimeter of the interfacing structure: 3) a cross-sectional profile of the connection portion; and4) in a cross-sectional profile of the cushioning component, an offset of an apex of the cushioning component with respect to the a centerline that intersects 1) the patient-contacting side of the cushioning component, and 2) a midpoint of a line extending along the base surface from an inner edge of the cushioning component to an outer edge of the cushioning component.
  • 29. The respiratory mask of claim 28, wherein each the following parameters of the interfacing structure varies around the perimeter of the interfacing structure: 3) the cross-sectional profile of the connection portion; and4) in the cross-sectional profile of the cushioning component, the offset of the apex of the cushioning component with respect to the centerline that intersects 1) the patient-contacting side of the cushioning component, and 2) the midpoint of the line extending along the base surface from the inner edge of the cushioning component to the outer edge of the cushioning component.
  • 30. The respiratory mask of claim 29, wherein the centerline intersects the patient-contacting side of the cushioning component in any cross-sectional profile of the cushioning component taken around the entire perimeter of the interfacing structure.
  • 31. The respiratory mask of claim 29, wherein the offset of the apex of the cross-sectional profile of the cushioning component in a cheek region of the interfacing structure is different than the offset in a lip region of the interfacing structure.
Priority Claims (2)
Number Date Country Kind
2008904769 Sep 2008 AU national
2008904778 Sep 2008 AU national
CROSS-REFERENCE TO APPLICATION

This application is a continuation of U.S. patent application Ser. No. 14/524,097, filed Oct. 27, 2014, now allowed, which is a continuation of U.S. patent application Ser. No. 12/737,919, filed Mar. 1, 2011, now U.S. Pat. No. 8,869,798, which is the U.S. National Phase of International Application No. PCT/AU2009/001144, filed Sep. 3, 2009, which designated the U.S. and claims the benefit of Australian Provisional Patent Application Nos. AU 2008904769, filed Sep. 12, 2008, and AU 2008904778, filed Sep. 15, 2008, each of which is hereby incorporated herein by reference in its entirety.

US Referenced Citations (404)
Number Name Date Kind
443191 Illing Dec 1890 A
781516 Guthrie, Jr. Jan 1905 A
1081745 Johnston Dec 1913 A
1125542 Humphries Jan 1915 A
1192186 Greene Jul 1916 A
1229050 Donald Jun 1917 A
1282527 Bidonde Oct 1918 A
1362766 McGargill Dec 1920 A
1445010 Feinberg Feb 1923 A
1610793 Kaufman Dec 1926 A
1873160 Sturtevant Aug 1932 A
2353643 Bulbulian Jul 1944 A
2415846 Randall Feb 1947 A
2433565 Korman Dec 1947 A
2625155 Engelder Jan 1953 A
2706983 Matheson et al. Apr 1955 A
2931356 Schwarz Apr 1960 A
3013556 Galleher Dec 1961 A
3670726 Mahon et al. Mar 1972 A
3682171 Dali et al. Aug 1972 A
3739774 Gregory Jun 1973 A
3754552 King Aug 1973 A
3815596 Keener Jun 1974 A
3861385 Carden Jan 1975 A
3902486 Guichard Sep 1975 A
3905361 Hewson et al. Sep 1975 A
3938614 Ahs Feb 1976 A
3972321 Proctor Aug 1976 A
3974829 Tate Aug 1976 A
4006744 Steer Feb 1977 A
4142527 Garcia Mar 1979 A
4153051 Shippert May 1979 A
4156426 Gold May 1979 A
4248218 Fischer Feb 1981 A
4263908 Mizerak Apr 1981 A
4264743 Maruyama et al. Apr 1981 A
4267845 Robertson, Jr. et al. May 1981 A
4273124 Zimmerman Jun 1981 A
4312359 Olson Jan 1982 A
4367735 Dali Jan 1983 A
4367816 Wilkes Jan 1983 A
4406283 Bir Sep 1983 A
4414973 Matheson et al. Nov 1983 A
4422456 Teip Dec 1983 A
4449526 Elam May 1984 A
4455675 Bose et al. Jun 1984 A
4493614 Chu et al. Jan 1985 A
4548200 Wapner Oct 1985 A
4549542 Chein Nov 1985 A
4572323 Randall Feb 1986 A
4587967 Chu et al. May 1986 A
4601465 Roy Jul 1986 A
4617637 Chu et al. Nov 1986 A
4630604 Montesi Dec 1986 A
4641647 Behan Feb 1987 A
4660555 Payton Apr 1987 A
4671271 Bishop et al. Jun 1987 A
4676241 Webb et al. Jun 1987 A
4699139 Marshall et al. Oct 1987 A
4706664 Snook et al. Nov 1987 A
4711636 Bierman Dec 1987 A
4713844 Westgate Dec 1987 A
D293613 Wingler Jan 1988 S
4753233 Grimes Jun 1988 A
4755040 Haslbeck Jul 1988 A
4767411 Edmunds Aug 1988 A
4774946 Ackerman et al. Nov 1988 A
4782832 Trimble et al. Nov 1988 A
4790829 Bowden et al. Dec 1988 A
4802857 Laughlin Feb 1989 A
4803981 Vickery Feb 1989 A
4811730 Milano Mar 1989 A
4830138 Palmaer et al. May 1989 A
4838878 Kalt et al. Jun 1989 A
4899740 Napolitano Feb 1990 A
4907584 McGinnis Mar 1990 A
4915105 Lee Apr 1990 A
4919128 Kopala et al. Apr 1990 A
4919654 Kalt Apr 1990 A
4944310 Sullivan Jul 1990 A
4945907 Tayebi Aug 1990 A
4960121 Nelson et al. Oct 1990 A
4966590 Kalt Oct 1990 A
4969880 Zamierowski Nov 1990 A
4971051 Toffolon Nov 1990 A
4976698 Stokley Dec 1990 A
4989599 Carter Feb 1991 A
4996983 Amrhein Mar 1991 A
5000173 Zalkin et al. Mar 1991 A
5005571 Dietz Apr 1991 A
5020163 Aileo et al. Jun 1991 A
5022900 Bar-Yona et al. Jun 1991 A
5023955 Murphy, II et al. Jun 1991 A
5025805 Nutter Jun 1991 A
5038772 Kolbe et al. Aug 1991 A
5042478 Kopala et al. Aug 1991 A
5046491 Derrick Sep 1991 A
5074297 Venegas Dec 1991 A
5113857 Dickerman et al. May 1992 A
5117818 Palfy Jun 1992 A
5121745 Israel Jun 1992 A
5127397 Kohnke Jul 1992 A
5137017 Salter Aug 1992 A
5138722 Urella et al. Aug 1992 A
D333015 Farmer et al. Feb 1993 S
5188101 Tumolo Feb 1993 A
5191824 Rathbun, Jr. Mar 1993 A
5207665 Davis et al. May 1993 A
5220699 Farris Jun 1993 A
5243709 Sheehan et al. Sep 1993 A
5243971 Sullivan et al. Sep 1993 A
5245995 Sullivan et al. Sep 1993 A
5261893 Zamierowski Nov 1993 A
5263939 Wortrich Nov 1993 A
5265592 Beaussant Nov 1993 A
5265595 Rudolph Nov 1993 A
5267557 Her-Mou Dec 1993 A
5269296 Landis Dec 1993 A
5271391 Graves Dec 1993 A
5304146 Johnson et al. Apr 1994 A
5299599 Farmer et al. May 1994 A
5335656 Bowe et al. Aug 1994 A
5349949 Schegerin Sep 1994 A
5355878 Griffiths et al. Oct 1994 A
5355893 Mick et al. Oct 1994 A
5364367 Banks et al. Nov 1994 A
5372130 Stem et al. Dec 1994 A
5372388 Gargiulo Dec 1994 A
5372389 Tam et al. Dec 1994 A
5372390 Conway et al. Dec 1994 A
5372391 Bast et al. Dec 1994 A
5375593 Press Dec 1994 A
5385141 Granatiero Jan 1995 A
5394568 Brostrom et al. Mar 1995 A
5396885 Nelson Mar 1995 A
5398676 Press et al. Mar 1995 A
5400776 Bartholomew Mar 1995 A
5419318 Tayebi May 1995 A
5425359 Liou Jun 1995 A
5429683 Le Mitouard Jul 1995 A
5437267 Weinstein et al. Aug 1995 A
5441046 Starr et al. Aug 1995 A
5462528 Roewer Oct 1995 A
5477852 Landis et al. Dec 1995 A
5526806 Sansoni Jan 1996 A
5488948 Dubruille et al. Feb 1996 A
5509409 Weatherholt Apr 1996 A
5513634 Jackson May 1996 A
5513635 Bedi May 1996 A
5533506 Wood Jul 1996 A
5538000 Rudolph Jul 1996 A
5538001 Bridges Jul 1996 A
5540223 Starr et al. Jul 1996 A
5560354 Berthon-Jones et al. Oct 1996 A
5570684 Behr Nov 1996 A
5592938 Scarberry et al. Jan 1997 A
5623923 Bertheau et al. Apr 1997 A
5626814 Vicino May 1997 A
5647357 Barnett et al. Jul 1997 A
5653228 Byrd Aug 1997 A
5655527 Scarberry et al. Aug 1997 A
5662101 Ogden et al. Sep 1997 A
5682881 Winthrop et al. Nov 1997 A
5704345 Berthon-Jones et al. Jan 1998 A
5707342 Tanaka Jan 1998 A
5724965 Handke et al. Mar 1998 A
5735272 Dillon et al. Apr 1998 A
5740799 Nielson Apr 1998 A
5752511 Simmons et al. May 1998 A
5794619 Edeiman et al. Aug 1998 A
5807341 Heim Sep 1998 A
5842469 Rapp et al. Dec 1998 A
5906203 Klockseth et al. May 1999 A
5918598 Belfer et al. Jul 1999 A
5921239 McCall et al. Jul 1999 A
5954049 Foley et al. Sep 1999 A
5975079 Hellings et al. Nov 1999 A
6019101 Cotner et al. Jan 2000 A
6026811 Settle Feb 2000 A
6044844 Kwok et al. Apr 2000 A
6082360 Rudolph et al. Jul 2000 A
6086118 McNaughton et al. Jul 2000 A
6095996 Steer et al. Aug 2000 A
6098205 Schwartz et al. Aug 2000 A
6109263 Feuchtgruber Aug 2000 A
6112746 Kwok et al. Sep 2000 A
6119693 Kwok et al. Sep 2000 A
6119694 Correa et al. Sep 2000 A
6123071 Berthon-Jones et al. Sep 2000 A
6123082 Berthon-Jones Sep 2000 A
6139787 Harrison Oct 2000 A
6152137 Schwartz et al. Nov 2000 A
6176164 Nylander Jan 2001 B1
6193914 Harrison Feb 2001 B1
6196223 Belfer et al. Mar 2001 B1
6211263 Cinelli et al. Apr 2001 B1
6231548 Bassett May 2001 B1
6241930 Harrison Jun 2001 B1
6258066 Urich Jul 2001 B1
6295366 Haller et al. Sep 2001 B1
6328038 Kessler et al. Dec 2001 B1
6341606 Bordewick et al. Jan 2002 B1
6347631 Hansen et al. Feb 2002 B1
6357441 Kwok et al. Mar 2002 B1
6358279 Tahi et al. Mar 2002 B1
6374826 Gunaratnam et al. Apr 2002 B1
6397847 Scarberry Jun 2002 B1
6412487 Gunaratnam et al. Jul 2002 B1
6412488 Barnett et al. Jul 2002 B1
6412593 Jones Jul 2002 B1
6419660 Russo Jul 2002 B1
6422238 Lithgow Jul 2002 B1
6423036 Van Huizen Jul 2002 B1
6431172 Bordewick Aug 2002 B1
6434796 Speirs Aug 2002 B1
6439234 Curti et al. Aug 2002 B1
6448303 Paul Sep 2002 B1
6467482 Boussignac Oct 2002 B1
6467483 Kopacko et al. Oct 2002 B1
6470887 Martinez Oct 2002 B1
6478026 Wood Nov 2002 B1
6482178 Andrews et al. Nov 2002 B1
6491034 Gunaratnam et al. Dec 2002 B1
6513526 Kwok et al. Feb 2003 B2
6530373 Patron et al. Mar 2003 B1
6532961 Kwok et al. Mar 2003 B1
6536435 Fecteau et al. Mar 2003 B1
6561188 Ellis May 2003 B1
6561190 Kwok et al. May 2003 B1
6561192 Palmer May 2003 B2
6561193 Noble May 2003 B1
6615832 Chen May 2003 B1
6571798 Thornton Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6581601 Ziaee Jun 2003 B2
6581602 Kwok et al. Jun 2003 B2
6584975 Taylor Jul 2003 B1
6595214 Hecker et al. Jul 2003 B1
6595215 Wood Jul 2003 B2
6607516 Cinelli et al. Aug 2003 B2
6627289 Dilnik et al. Sep 2003 B1
6631718 Lovell Oct 2003 B1
6634358 Kwok et al. Oct 2003 B2
6637434 Noble Oct 2003 B2
6644315 Ziaee Nov 2003 B2
6655385 Curti et al. Dec 2003 B1
6663600 Bierman et al. Dec 2003 B2
6669712 Cardoso Dec 2003 B1
D485905 Moore et al. Jan 2004 S
6679257 Robertson et al. Jan 2004 B1
6679265 Strickland et al. Jan 2004 B2
6701927 Kwok et al. Mar 2004 B2
6710099 Cinelli et al. Mar 2004 B2
6766800 Chu et al. Jul 2004 B2
6766817 da Silva Jul 2004 B2
6776162 Wood Aug 2004 B2
6776163 Dougill et al. Aug 2004 B2
6789543 Cannon Sep 2004 B2
6805117 Ho et al. Oct 2004 B1
6807967 Wood Oct 2004 B2
6817362 Gelinas et al. Nov 2004 B2
6820617 Robertson et al. Nov 2004 B2
6823865 Drew et al. Nov 2004 B2
6823869 Raje et al. Nov 2004 B2
6834650 Fini Dec 2004 B1
6851429 Bishop Feb 2005 B2
6860270 Sniadach Mar 2005 B2
6895965 Scarberry et al. May 2005 B2
6907882 Ging et al. Jun 2005 B2
6918404 Dias da Silva Jul 2005 B2
6926004 Schumacher Aug 2005 B2
6938620 Payne, Jr. Sep 2005 B2
6968844 Liland Nov 2005 B2
6972003 Bierman et al. Dec 2005 B2
6986352 Frater et al. Jan 2006 B2
6997177 Wood Feb 2006 B2
7011090 Drew et al. Mar 2006 B2
7018362 Bierman et al. Mar 2006 B2
7021311 Gunaratnam et al. Apr 2006 B2
7052127 Harrison May 2006 B2
7066586 da Silva Jun 2006 B2
7076282 Munro et al. Jul 2006 B2
7080645 Genger et al. Jul 2006 B2
7101359 Kline et al. Sep 2006 B2
7107989 Frater et al. Sep 2006 B2
7146976 McKown Dec 2006 B2
7152599 Thomas Dec 2006 B2
7152601 Barakat et al. Dec 2006 B2
7191781 Wood Mar 2007 B2
7207328 Altemus Apr 2007 B1
7207334 Smart Apr 2007 B2
7210481 Lovell et al. May 2007 B1
7237551 Ho et al. Jul 2007 B2
7243723 Surjaatmadja Jul 2007 B2
D550836 Chandran et al. Sep 2007 S
D552733 Criscuolo et al. Oct 2007 S
7285255 Kadlec et al. Oct 2007 B2
7287528 Ho Oct 2007 B2
7302950 Berthon-Jones et al. Dec 2007 B2
7318437 Gunaratnam et al. Jan 2008 B2
7318439 Raje et al. Jan 2008 B2
7523754 Lithgow Apr 2009 B2
7658189 Davidson Feb 2010 B2
8684004 Eiffer Apr 2014 B2
8701667 Ho Apr 2014 B1
9937312 Kwok Apr 2018 B2
9987450 Veliss Jun 2018 B2
10265489 Wells Apr 2019 B2
20010020474 Hecker et al. Sep 2001 A1
20020005198 Kwok et al. Jan 2002 A1
20020029780 Frater et al. Mar 2002 A1
20020046755 Devoss Apr 2002 A1
20020053347 Ziaee May 2002 A1
20020066452 Kessler et al. Jun 2002 A1
20020069872 Gradon et al. Jun 2002 A1
20020096178 Ziaee Jul 2002 A1
20020124849 Billette De Villemeur Sep 2002 A1
20020143296 Russo Oct 2002 A1
20020157673 Kessler et al. Oct 2002 A1
20020174868 Kwok et al. Nov 2002 A1
20020185134 Bishop Dec 2002 A1
20030000526 Goebel Jan 2003 A1
20030019495 Palkon et al. Jan 2003 A1
20030019496 Kopacko et al. Jan 2003 A1
20030075180 Raje et al. Apr 2003 A1
20030079749 Strickland et al. May 2003 A1
20030089373 Gradon et al. May 2003 A1
20030111080 Olsen et al. Jun 2003 A1
20030154980 Berthon-Jones et al. Aug 2003 A1
20030168063 Gambone et al. Sep 2003 A1
20030196656 Moore et al. Oct 2003 A1
20030196658 Ging et al. Oct 2003 A1
20040025882 Mada et al. Feb 2004 A1
20040025885 Payne, Jr. Feb 2004 A1
20040045551 Eaton et al. Mar 2004 A1
20040065328 Amarasinghe et al. Apr 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040107968 Griffiths Jun 2004 A1
20040111104 Schein et al. Jun 2004 A1
20040112384 Lithgow et al. Jun 2004 A1
20040118406 Lithgow et al. Jun 2004 A1
20040127856 Johnson Jul 2004 A1
20040133958 Darnell Jul 2004 A1
20040211428 Jones, Jr. Oct 2004 A1
20040226564 Persson Nov 2004 A1
20040226566 Gunaratnam et al. Nov 2004 A1
20050011523 Aylsworth et al. Jan 2005 A1
20050028822 Sleeper et al. Feb 2005 A1
20050033247 Thompson Feb 2005 A1
20050039757 Wood Feb 2005 A1
20050051171 Booth Mar 2005 A1
20050051176 Riggins Mar 2005 A1
20050056286 Huddart et al. Mar 2005 A1
20050061326 Payne, Jr. Mar 2005 A1
20050101933 Marrs et al. May 2005 A1
20050121030 Bateman Jun 2005 A1
20050150495 Rittner et al. Jul 2005 A1
20050155604 Ging et al. Jul 2005 A1
20050172969 Ging Aug 2005 A1
20050211252 Lang et al. Sep 2005 A1
20050241644 Gunaratnam et al. Nov 2005 A1
20050257792 Wixey Nov 2005 A1
20050284481 Meyer Dec 2005 A1
20060042629 Geist Mar 2006 A1
20060060200 Ho et al. Mar 2006 A1
20060081250 Bordewick et al. Apr 2006 A1
20060095008 Lampropoulos et al. May 2006 A1
20060095009 Lampropoulos et al. May 2006 A1
20060096598 Ho et al. May 2006 A1
20060107960 Smart May 2006 A1
20060118117 Berthon-Jones Jun 2006 A1
20060124131 Chandran et al. Jun 2006 A1
20060130844 Ho Jun 2006 A1
20060137690 Gunaratnam et al. Jun 2006 A1
20060174887 Chandran et al. Aug 2006 A1
20060207597 Wright Sep 2006 A1
20060207599 Busch Sep 2006 A1
20060237017 Davidson et al. Oct 2006 A1
20060237018 McAuley et al. Oct 2006 A1
20060283461 Lubke et al. Dec 2006 A1
20060289010 Kwok et al. Dec 2006 A1
20070023044 Kwok et al. Feb 2007 A1
20070125387 Zollinger et al. Jun 2007 A1
20070144525 Davidson et al. Jun 2007 A1
20070186930 Davidson et al. Aug 2007 A1
20070272249 Chandran et al. Nov 2007 A1
20070282272 Bannon et al. Dec 2007 A1
20080004573 Kaufmann et al. Jan 2008 A1
20080006277 Worboys et al. Jan 2008 A1
20080047560 Veliss et al. Feb 2008 A1
20080060649 Veliss Mar 2008 A1
20080065022 Kyvik et al. Mar 2008 A1
20080110469 Weinberg May 2008 A1
20080149104 Eifler Jun 2008 A1
20080200880 Kyvik et al. Aug 2008 A1
20080257354 Davidson et al. Oct 2008 A1
20080314390 Kwok Dec 2008 A1
20090014007 Brambilla et al. Jan 2009 A1
20090044808 Guney et al. Feb 2009 A1
20100000534 Kooij et al. Jan 2010 A1
20100018534 Veliss et al. Jan 2010 A1
20110146684 Wells et al. Jun 2011 A1
20150040912 Wells et al. Feb 2015 A1
20180140791 Jones May 2018 A1
Foreign Referenced Citations (120)
Number Date Country
199651130 Oct 1996 AU
2005100738 Nov 2005 AU
1553820 Dec 2004 CN
1628870 Jun 2005 CN
1681553 Oct 2005 CN
1784250 Jun 2006 CN
1901962 Jan 2007 CN
101128233 Feb 2008 CN
101155610 Apr 2008 CN
101155618 Apr 2008 CN
101389369 Mar 2009 CN
185017 May 1907 DE
30 11 900 Oct 1980 DE
146 688 Feb 1981 DE
37 19 009 Dec 1988 DE
39 27 038 Feb 1991 DE
297 23 101 Jul 1998 DE
197 03 526 Aug 1998 DE
199 44 242 Mar 2001 DE
10002571 Jul 2001 DE
102 13 905 Oct 2002 DE
10 2004 055 433 Nov 2004 DE
0 288 937 Nov 1988 EP
0 427 474 May 1991 EP
0 466 960 Jan 1992 EP
0 303 090 Apr 1992 EP
0 658 356 Jun 1995 EP
0 776 679 Jun 1997 EP
1 099 452 May 2001 EP
1 147 782 Oct 2001 EP
1 258 266 Nov 2002 EP
1 481 702 Dec 2004 EP
1 982 740 Apr 2008 EP
1982740 Oct 2008 EP
2 259 828 Dec 2010 EP
2 720 280 Dec 1995 FR
2 823 122 Oct 2002 FR
532214 Jan 1941 GB
2 176 404 Dec 1986 GB
2 368 533 May 2002 GB
2376896 Dec 2002 GB
2 385 533 Aug 2003 GB
2000-515784 Nov 2000 JP
2002-028240 Jan 2002 JP
2006-505373 Feb 2006 JP
2006-326129 Dec 2006 JP
2008-526393 Jul 2008 JP
2009-520579 May 2009 JP
2011-512968 Apr 2011 JP
WO 1982003548 Oct 1982 WO
WO 1987001950 Apr 1987 WO
WO 1992020392 Nov 1992 WO
WO 1992020395 Nov 1992 WO
WO 1996028207 Sep 1996 WO
WO 1998004310 Feb 1998 WO
WO 1998012965 Apr 1998 WO
WO 1998023305 Jun 1998 WO
WO 1999016327 Apr 1999 WO
WO 1999025410 May 1999 WO
WO 1999043375 Sep 1999 WO
WO 1999061088 Dec 1999 WO
WO 2000020072 Apr 2000 WO
WO 2000038772 Jul 2000 WO
WO 2000050121 Aug 2000 WO
WO 0069521 Nov 2000 WO
WO 2000072905 Dec 2000 WO
WO 2000074758 Dec 2000 WO
WO 2000076568 Dec 2000 WO
WO 2000078384 Dec 2000 WO
WO 2001062326 Aug 2001 WO
WO 2001095965 Dec 2001 WO
WO 2001097892 Dec 2001 WO
WO 2001097893 Dec 2001 WO
WO 2002038221 May 2002 WO
WO 2002045784 Jun 2002 WO
WO 03082406 Oct 2003 WO
WO 2003090827 Nov 2003 WO
WO 2003105921 Dec 2003 WO
WO 2004022146 Mar 2004 WO
WO 2004041342 May 2004 WO
WO 2004073778 Sep 2004 WO
WO 2004078230 Sep 2004 WO
WO 2005053781 Jun 2005 WO
WO 2005063326 Jul 2005 WO
WO 2005063328 Jul 2005 WO
WO 2005086943 Sep 2005 WO
WO 2005099801 Oct 2005 WO
WO 2005110220 Nov 2005 WO
WO 2005118040 Dec 2005 WO
PCTAU2006000031 Jan 2006 WO
PCTAU2006000417 Mar 2006 WO
PCTAU2006000770 Jun 2006 WO
WO 2006069415 Jul 2006 WO
WO 2006074513 Jul 2006 WO
WO 2006074516 Jul 2006 WO
WO-2006074513 Jul 2006 WO
WO 2006099658 Sep 2006 WO
WO 2006113321 Oct 2006 WO
WO 2006130903 Dec 2006 WO
WO 2007009182 Jan 2007 WO
WO 2007041751 Apr 2007 WO
WO 2007041786 Apr 2007 WO
WO 2007048174 May 2007 WO
WO 2007053878 May 2007 WO
WO 2007068044 Jun 2007 WO
WO 2007115153 Oct 2007 WO
WO 2007120355 Oct 2007 WO
PCTAU2007001936 Dec 2007 WO
WO 2007143772 Dec 2007 WO
WO 2007145534 Dec 2007 WO
WO 2008011682 Jan 2008 WO
WO 2008011683 Jan 2008 WO
WO 2008040050 Apr 2008 WO
WO 2008063923 May 2008 WO
WO 2008070929 Jun 2008 WO
PCTAU2009000262 Mar 2009 WO
WO 2009108994 Sep 2009 WO
WO 2009109004 Sep 2009 WO
WO 2010028425 Mar 2010 WO
WO 2010148453 Dec 2010 WO
Non-Patent Literature Citations (152)
Entry
NZ First Examination Report mailed Dec. 24, 2020 in corresponding NZ Application 770159 (3 pages).
U.S. Final Office Action mailed Dec. 30, 2020 in related U.S. Appl. No. 15/987,734 (13 pages).
Extended EP Search Report mailed Feb. 16, 2021 in related EP Application 21174225.9 (19 pages).
Chinese Notification of the Third Office Action and English translation thereof mailed May 12, 2020 in related Chinese application 201611072310.X.
NZ Further Examination Report mailed Jun. 17, 2020 in corresponding NZ application 754381.
EP Summons to attend oral proceedings pursuant to Rule 115(1) EPC mailed Dec. 11, 2020 in corresponding EP Application 09812518.0 (5 pages).
U.S. Office Action mailed Sep. 21, 2020 in related U.S. Appl. No. 15/998,734 (45 pages).
CN Office Action and English translation thereof mailed Nov. 6, 2020 in related CN Application 201611072310.X (15 pages).
Chinese Notification of the Second Office Action and English translation thereof mailed Sep. 5, 2019 in Chinese application 201611072310.X.
International Preliminary Report on Patentability mailed Jul. 8, 2010 in related PCT application PCT/AU2009/000262.
EP Communication pursuant to Article 94(3) EPC mailed Apr. 14, 2019 in related EP application 09716805.8.
NZ First Examination Report mailed Mar. 11, 2019 in related AU application 751320.
NZ Further Examination Report mailed May 16, 2019 in related AU application 751320.
EP Communication pursuant to Article 94(3) EPC mailed Mar. 13, 2019 in corresponding EP Application 09812518.0.
CN Examination Decision on Request for Reexamination and English translation thereof mailed Apr. 3, 2019 in related CN Application 201510114255.5.
NZ First Examination Report mailed Jun. 14, 2019 in corresponding NZ application 754381.
Third Office Action issued in corresponding Chinese Application No. 200980136031.7 on Jun. 20, 2014 with English-language translation thereof (8 pages).
Notice of Allowance issued Apr. 28, 2014 in corresponding Japanese Application No. 2011-526353.
Second Office Action issued in corresponding Chinese Application No. 200980136031.7 on Nov. 19, 2013 with English-language translation thereof.
Notice of Reasons for Rejection issued in corresponding Japanese Application No. 2011-526353 on Oct. 8, 2013 with English-language translation.
Patent Examination Report No. 1 issued in corresponding Australian Patent Application No. 2009291491 on Oct. 8, 2013.
Chinese Office Action issued in corresponding Chinese Application No. 200980136031.7 dated Feb. 27, 2013.
Examination Report for corresponding New Zealand Application No. 591308, mailed Jun. 21, 2012, 2 pages.
Supplementary European Search Report issued Dec. 18, 2009 in European Application No. 03810331.3.
International Search Report issued in PCT/AU2009/001144 (Dec. 18, 2009).
“Ear Loop Face Mask”, USPTO to assume before Applicant's filing date.
Adam J. Singer MD et al. “The Cyanoacrylate Topical Skin Adhesives,” American Journal of Emergency Medicine, Vol. 26, 2008, pp. 490-496.
Webster's Third New International Dictionary, 1993, Dictionary definition for adjustable, bendable, and mild steel.
ComfortLite™, Respironics, http://comfortlite.respironics.com, USPTO to assume before Applicant's filing date.
ComfortLite™ 2, Respironics, http://comfortlite2.respironics.com, USPTO to assume before Applicant's filing date.
“If You Hate CPAP! You Need CPAP Pro®,” www.cpappro.com, USPTO to assume before Applicant's filing date.
Webster's New World Dictionary, Third College Edition 1988, definition for engaged and flexible.
EP Supplementary Search Report issued in EP Application 03793493, dated Dec. 2, 2009.
European Search Report filed on Jul. 27, 2009 in EP Application No. 07784697.0.
European Search Report issued in EP 07845378.4, mailed Dec. 1, 2009.
Examination Report filed in New Zealand Application 539836, dated Aug. 25, 2005.
Examiner's Report No. 3 mailed Nov. 18, 2009 in New Zealand Application No. 2003275762.
Extended European Search Report dated Mar. 19, 2009 in European Application No. EP 08161249.
Extended European Search Report Mailed Sep. 3, 2009 in corresponding EP Application No. 09161984.1.
Extended European Search Report. Application No. EP 08154854, dated Nov. 27, 2008.
Fisher and Paykel Col.—Product Family—http://www.fphcare.com/osa/products.asp/, USPTO to assume before Applicant's filing date.
Hans Rudolph, Inc.—Mask Products—http://www.rudolphkc.com/products.php?category=MASKS, USPTO to assume before Applicant's filing date.
International Preliminary Report on Patentability for PCT/AU2004/001832, dated Jul. 3, 2006.
International Search Report filed in PCT/AU2005/000803, dated Jun. 30, 2005.
International Search Report filed in PCT/AU2006/000770, dated Aug. 3, 2006.
International Search Report for PCT/AU2007/001052, dated Oct. 9, 2007.
International Search Report for PCT/AU2007/001051, dated Nov. 5, 2007.
International Search Report for PCT/AU2004/001832, dated Mar. 24, 2005.
International Search Report for PCT/AU2007/001936, dated Mar. 4, 2008.
Joel W. Beam, “Tissue Adhesives for Simple Traumatic Lacerations,” Journal of Athletic Training, 2008, vol. 43, No. 2, pp. 222-224.
Merriam-Webster Online Dictionary definition of moveable from the 14th century.
Office Action mailed Dec. 22, 2009 in European Appln. No. 04802133.1.
Office Action issued in Japanese Application No. 2007-513621 (Aug. 24, 2010) with English translation.
ResMed Co.—Mask Products—http://resmed.com/portal/site/ResMedUS/index.jsp? , USPTO to assume before Applicant's filing date.
Respironics Co.—Mask Family—http://masksfamily.respironics.com/, USPTO to assume before Applicant's filing date.
Snapp Nasal Interface, Tiara Medical Systems, Inc.—http://www.tiaramed.com/asp_shops/shopdisplayproducts.asp?id=109&cat=SNAPP%2A+Nasal+Interface, USPTO to assume before Applicant's filing date.
Unsolicited email from Elson Silva, PhD, dated Mar. 28, 2008, “Requesting IDS of U.S. Pat. No. 6,766,817 for patents on fluids moving on porosity by Unsaturated Hydraulic Flow,” (email provided in both HTML and plain text format).
International Search Report PCT/AU2003/001163, dated Nov. 4, 2003.
International Search Report PCT/AU2003/001471, dated Feb. 12, 2004.
International Search Report PCT/AU2009/000240, dated May 21, 2009.
International Search Report PCT/AU2009/000262, dated Jun. 9, 2009.
Office Action issued in European Application No. 05746824.1 (Mar. 22, 2011).
Supplementary European Search Report mailed Dec. 18, 2009 in European Application No. 03810331.3.
Supplementary European Search Report mailed Sep. 8, 2009 in European Appln. No. 04802133.1.
Subbu Venkatraman et al., “Review Skin Adhesives and Skin Adhesion 1. Transdermal Drug Delivery Systems,” Biomaterials, vol. 19, 1998, pp. 1119-1136.
Patent Examination Report No. 2 issued Nov. 26, 2014 in corresponding Australian Patent Application No. 2009291491.
Further Examination Report issued in corresponding New Zealand Patent Appln. No. 615630, dated Mar. 20, 2015 (2 pages).
Further Examination Report issued in corresponding New Zealand Patent Appln. No. 615630, dated Apr. 10, 2015 (2 pages).
Patent Examination Report No. 3 issued Jun. 3, 2015 in a corresponding Australian Patent Application No. 2009291491 (3 pages).
Requisition by the Examiner issued May 29, 2015, in a corresponding Canadian Application No. 2,735,986 (4 pages).
Office Action issued Jun. 8, 2015 in a corresponding Japanese Patent Application No. 2014-109892 (3 pages) and English translation thereof (4 pages).
Office Action issued Jun. 30, 2015 in a related U.S. Appl. No. 12/736,030 (13 pages).
Communication including extended European Search Report issued Aug. 26, 2015, in a corresponding European Application No. 09 81 258.0 (11 pages).
Notice of Opposition to Grant of Patent filed Sep. 29, 2015 in a corresponding New Zealand Application No. 615630 (5 pages).
Further Examination Report issued Nov. 11, 2015 in a corresponding New Zealand Application No. 705201 (2 pages).
Deadline for Counterstatement issued Jan. 5, 2016 in a corresponding New Zealand Application No. 615630 (1 page), Amended Notice of Opposition filed Nov. 27, 2015 (both markup and clean) (6 pages), and Statement of the Case filed Nov. 27, 2015 (9 pages).
Notification of Reexamination issued Feb. 23, 2016 in a related Chinese Application No. 200980107829.9 (7 pages) and English translation thereof (8 pages).
Patent Examination Report No. 1 issued Mar. 11, 2016 in a related Australian Application No. 2015200781 (5 pages).
First Examination Report issued Apr. 5, 2016, in a related New Zealand Application No. 717325 (2 pages).
First Office Action issued Jul. 28, 2016 in a related Chinese Application No. 201510114255.5 (10 pages), and an English translation thereof (10 pages).
Notice of Allowance issued Oct. 7, 2016, in a corresponding Japanese Application No. 2015-109892 (3 pages).
Examination Decision of the Patent Examination Board issued Aug. 30, 2016, in a related Chinese Application No. 200980107829.9 (11 pages) and an English translation thereof (12 pages).
First Office Action issued Sep. 5, 2016, in a corresponding Chinese application No. 201510141153.2 (11 pages), and an English translation thereof (13 pages).
Patent Examination Report No. 2 issued Nov. 24, 2016 in a related Australian Application No. 2015200781 (3 pages).
Examination Report No. 1 issued Jan. 20, 2017, in a corresponding Australian Application No. 2015238868 (8 pages).
Office Action issued Mar. 10, 2017 in a related U.S. Appl. No. 12/736,030 (23 pages).
Further Examination Report issued Jun. 19, 2017 in a related New Zealand Application No. 717325 (2 pages).
Communication Pursuant to Article 94(3) EPC issued Jun. 20, 2017, in a related European Application No. 09 716 805.8 (8 pages).
Office Action issued Jun. 13, 2017, in a corresponding Canadian Application No. 2,941,584 (3 pages).
Second Office Action issued Jul. 19, 2016, in a corresponding Chinese Patent Application No. 201510141153.2 (9 pages), and an English translation thereof (12 pages).
Decision of Rejection issued Aug. 8, 2017, in a related Chinese Application No. 201510114255.5 (18 pages), and an English translation thereof (21 pages).
Second Office Action issued Feb. 13, 2017 in a related Chinese Application No. 2015101142555 (16 pages), and an English translation thereof (19 pages).
Final Office Action issued Sep. 21, 2017, in a related U.S. Appl. No. 12/736,030 (13 pages).
First Examination Report issued Jul. 12, 2016, in a corresponding New Zealand Patent Application No. 719072 (3 pages).
First Examination Report issued Sep. 22, 2017, in a related New Zealand Patent Application No. 733524 (2 pages).
Office Action mailed Oct. 23, 2017, in a corresponding Japanese Patent Application No. 2016-216279 (2 pages), and an English translation thereof (3 pages).
Further Examination Report issued Dec. 4, 2017, in a corresponding New Zealand Patent Application No. 719072 (1 page).
Requisition by the Examiner issued Dec. 14, 2017, in a corresponding Canadian Patent Application No. 2,941,584 (3 pages).
Second Examination Report dated Sep. 22, 2017 in corresponding Australian Patent Application No. 2015238868 (4 pages).
Third Examination Report dated Jan. 16, 2018, in corresponding Australian Patent Application No. 2015238868 (4 pages).
Third Office Action issued Feb. 8, 2018, in a corresponding Chinese Patent Application No. 2015101411532 (3 pages), and an English translation thereof (5 pages).
First Examination Report issued Jan. 9, 2018, in a corresponding New Zealand Patent Application No. 738034 (3 page).
Further Examination Report issued in corresponding New Zealand Application No. 738034, dated Aug. 6, 2018 (2 pages).
Further Examination Report issued in related New Zealand Application No. 735524 dated Dec. 6, 2018, (3 pages).
Further Examination Report issued in corresponding New Zealand Application No. 738034 dated Nov. 27, 2018, (2 pages).
U.S. Appl. No. 10/385,701, filed Aug. 2003, Berthon-Jones et al.
U.S. Appl. No. 10/533,928, filed Jul. 2005, Berthon-Jones.
U.S. Appl. No. 10/584,711, filed Dec. 2004, Davidson.
U.S. Appl. No. 10/655,622, filed Sep. 2003, Lithgow.
U.S. Appl. No. 10/781,929, filed Jan. 2008, Gunaratnam et al.
U.S. Appl. No. 10/871,929, filed Feb. 2004, Surjaatmadja.
U.S. Appl. No. 11/080,446, filed Jul. 2005, Ging et al.
U.S. Appl. No. 11/447,295, filed Jun. 2006, Lubke et al.
U.S. Appl. No. 11/474,415, filed Jun. 2006, Davidson et al.
U.S. Appl. No. 11/491,016, filed Feb. 2007, Kwok et al.
U.S. Appl. No. 11/703,082, filed Feb. 2007, Davidson.
U.S. Appl. No. 11/878,932, filed Jul. 2007, Veliss et al.
U.S. Appl. No. 11/878,933, filed Jul. 2007, Veliss et al.
U.S. Appl. No. 12/081,696, filed Apr. 2008, Davidson et al.
U.S. Appl. No. 12/085,191, filed May 2008, Kwok et al.
U.S. Appl. No. 12/219,852, filed Jul. 2008, Guney et al.
U.S. Appl. No. 12/309,696, filed Jan. 2009, Kwok et al.
U.S. Appl. No. 12/382,517, filed Mar. 2009, Lithgow.
U.S. Appl. No. 12/448,250, filed Jun. 2009, Veliss et al.
U.S. Appl. No. 12/461,448, filed Aug. 2009, Berthon-Jones.
U.S. Appl. No. 12/478,537, filed Jun. 2009, Kooij et al.
U.S. Appl. No. 12/656,466, filed Jan. 2010, Biener et al.
U.S. Appl. No. 12/700,878, filed Feb. 2010, Davidson et al.
U.S. Appl. No. 60/424,686, filed Nov. 2002, Lithgow.
U.S. Appl. No. 60/483,622, filed Jul. 2003, Kwok et al.
U.S. Appl. No. 60/533,214, filed Dec. 2003, Drew.
U.S. Appl. No. 60/634,802, filed Dec. 2004, Chandran.
U.S. Appl. No. 60/645,672, filed Jan. 2005, Chandran.
U.S. Appl. No. 60/795,615, filed Apr. 2006, Judson et al.
U.S. Appl. No. 60/833,841, filed Jul. 2006, Veliss.
U.S. Appl. No. 60/835,442, filed Aug. 2006, Selvarajan et al.
U.S. Appl. No. 60/852,649, filed Oct. 2006, Selvarajan et al.
U.S. Appl. No. 60/874,968, filed Dec. 2006, Kwok et al.
U.S. Appl. No. 60/907,856, filed Apr. 2007, Davidson et al.
U.S. Appl. No. 60/924,241, filed May 2007, Kwok et al.
U.S. Appl. No. 60/929,393, filed Jun. 2007, Kwok et al.
U.S. Appl. No. 60/935,179, filed Jul. 2007, Guney et al.
U.S. Appl. No. 60/935,336, filed Aug. 2007, Davidson et al.
U.S. Appl. No. 60/996,160, filed Nov. 2007, Guney et al.
U.S. Appl. No. 61/006,409, filed Jan. 2008, Guney et al.
U.S. Appl. No. 61/064,818, filed Mar. 2008, Guney et al.
U.S. Appl. No. 61/071,512, filed May 2008, Guney et al.
U.S. Appl. No. 61/213,326, filed May 2009, Dravitzki et al.
U.S. Appl. No. 61/222,711, filed Jul. 2009, Dravitzki et al.
U.S. Appl. No. 61/263,175, filed Nov. 2009, Dravitzki et al.
U.S. Appl. No. 61/272,162, filed Aug. 2009, Dravitzki et al.
U.S. Appl. No. 61/272,250, filed Sep. 2009, Dravitzki et al.
Related Publications (1)
Number Date Country
20190192800 A1 Jun 2019 US
Continuations (2)
Number Date Country
Parent 14524097 Oct 2014 US
Child 16288495 US
Parent 12737919 US
Child 14524097 US